Top

Katherine A. Hutcheson, Ph.D.

Department of Head and Neck Surgery, Division of Surgery

About Dr. Katherine A. Hutcheson

Dr. Katherine A. Hutcheson is a Professor in the Department of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center. She is the Chief for Speech Pathology and Audiology. She serves as the Director of Research in the Section of Speech Pathology and Audiology. She is the Director of the Voice Center and AUD Fellowship Director and is a lecturer at the University of Houston. Dr. Hutcheson is a certified Speech-Language Pathologist with a Doctorate Degree in Epidemiology. Dr. Hutcheson has authored over 100 peer-reviewed and invited articles with funding support from the National Institutes of Health, the MD Anderson Institutional Research Grant Award program, and a fellowship award from the Cancer Prevention Research Institute of Texas UT Health Innovation Training Program. She has also authored or co-authored 12 book chapters. Dr. Hutcheson is a Board Certified Specialist in Swallowing and Swallowing Disorders (BCS-S). She is an accomplished clinician and educator who lectures nationally and internationally on radiation associated dysphagia and head and neck cancer rehabilitation. The mission of her research is to optimize functional outcomes and quality of life in head and neck cancer survivorship. She directs a line of practice-oriented research in functional outcomes of head and neck cancer with emphasis on radiation associated dysphagia.

Primary Appointment

Adjunct Professor, Department of Communication Sciences and Disorders, Division of Surgery, The University of Houston College of Liberal Arts and Social Sciences, Houston, Texas

Professor, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Section Chief, Speech Pathology and Audiology, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Research Interests

Speech and swallowing function after head and neck cancer treatment.

Measurement of functional outcomes in head and neck cancer patients.

Complications and outcomes of surgical prosthetic voice restoration after laryngectomy.

Radiation-associated dysphagia.

Education & Training

Degree-Granting Education

2010	The University of Texas School of Public Health, Houston, Texas, US, Ph.D. in Epidemiology, Minor: Biostatistics, Behavioral Science
2004	Baylor University, Waco, Texas, US, M.S. in Communication Sciences and Disorders
2002	Baylor University, Waco, Texas, US, B.A. in Communication Sciences and Disorders

Postgraduate Training

2011-2013

Research Fellowship, UT Health Innovation for Cancer Prevention Research, University of Texas School of Public Health, Houston, Texas

Board Certifications

2012	Board Certified Swallowing Specialist awarded by The Specialty Board on Swallowing and Swallowing Disorders, American Speech-Language-Hearing Association

Experience & Service

Academic Appointments

Associate Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2020

Associate Professor, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2020

Assistant Professor, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2015

Administrative Appointments/Responsibilities

Deputy Director Clinical Research, Department of Head and Neck Surgery - Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present

Associate Director of Research for the Section of Speech Pathology and Audiology, Department of Head and Neck Surgery - Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2020

Section Leader, Stiefel Oropharynx Program, PRO/Function Section, Department of Head and Neck Surgery - Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2022

Other Appointments/Responsibilities

Speech-Language Pathologist, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2010

Institutional Committee Activities

Board Member, DRS Board Committee, 2025 - Present

Member, Clinical Health Education Programs, 2021 - Present

Member, Faculty Search Committee - Head and Neck Surgery, 2021 - Present

Member, Clinical Database Data Governance Committee, MD Anderson Stiefel Oropharynx Program, 2021 - Present

PRO Workstream Representative, D3CODE Committee- MDACC Committee- co led by Andy Futreal and David Jaffray, 2020 - 2021

Member, Head and Neck Surgery Clinical Operations Team (HNS COLT), 2020 - Present

Ad Hoc Member, Head and Neck Surgery Clinical Operations Team (HNS COLT), 2019 - 2020

Committee, Head and Neck Surgeon Scientist Search Committee, 2019 - Present

Member, Algorithm Head and Neck Survivorship, 2017 - Present

Member, Advisory Committee Head and Neck Surgery Chair Search Committee, 2017 - 2017

Member, Symptom Research Chair Search Committee, 2017 - 2018

Member, Head and Neck Clinical Trials Accruals Working Group, 2017 - Present

Chair, Survivorship Head and Neck Research Work Group, 2017 - 2020

Member, Joint Head and Neck Radiotherapy-MRI Development Cooperative, 2016 - Present

Charter Member, Enhanced Recovery Visual Language Project, 2015 - 2016

Member, Patient-Reported Outcomes (PRO) Survey Functionality in EPIC Advisory and Consulting Committee, 2015 - Present

Member, Speech Pathology and Audiology Epic Build Team, 2014 - 2016

Member, Faculty Senate, 2014 - 2017

Member, United Healthcare Bundled Payment Working Group, 2014 - 2016

Member, Patient-Reported Outcomes, Survey and Population Research (PROSPR) Shared Resource Advisory Committee, 2013 - Present

Member, MD Anderson Cancer Center Education Subcommittee for Research Billing, 2011 - 2014

Member, Ad Hoc Head and Neck Surgery Clinician Investigator Committee, 2011 - 2013

Honors & Awards

2023	Fellows Award, American Speech-Language-Hearing Association
2022	2022 Best Elevator Speech Competition Winner: Ella Aldridge, MD Anderson Cancer Center
2022	American Speech-Language-Hearing Association Fellow Award, ASHA
2022	Mentor Award - 2022 IGCT Summer Student Showcase “Best Potential for Clinical Impact!", The Image Guided Cancer Therapy Research Program
2021	Head and Neck Cancer Alliance Award, Dysphagia Research Society
2020 - 2021	Dissemination & Implementation Science Travel Award, American Speech-Language-Hearing Association
2020	Robert M. Chamberlain Distinguished Mentor Award, Finalist, The University of Texas MD Anderson Postdoctoral Association
2018	Poster of Distinction, 2018 American Head and Neck Society Meeting/Combined Otolaryngology Spring Meetings
2012	Best Faculty Poster Award, Cancer Survivorship Research Retreat, The University of Texas MD Anderson Cancer Center
2012	Poster Competition Award, 2nd place, Triological Society 2012 Combined Sections Meeting, Miami Beach, FL
2012	Winner, 2nd Place Scientific Abstract: Oral Presentation, 20th Annual Dysphagia Research Society Meeting
2011	Poster Competition Award, 2011 Oral Oncology: Oncologic Dentistry & Maxillofacial Prosthetics Symposium, The University of Texas MD Anderson Cancer Center
2008	Travel Award, American Speech-Language-Hearing Association Lessons for Success Research Conference: Developing the Emerging Scientist
2008	Yul Brynner Foundation and ASHA Special Interest Division 13-Swallowing and Swallowing Disorders New Investigators Grant, Dysphagia Research Society 16th Annual Meeting
2007 - 2008	ASHA Award for Continuing Education, American Speech-Language-Hearing Association
2007	ASHA Research Mentoring Pair Travel Award, American Speech-Language-Hearing Association 17th Annual Research Symposium: Genetic and Biological Pathways Underpinning Communication Disorders Across the Lifespan
2007	Science and Research Team Convention Registration Award, American Speech-Language-Hearing Association
2005	ASHA Convention Registration Award for Research for Recent Graduates, American Speech-Language-Hearing Association Special Interest Division 2-Neurophysiology and Neurogenic Speech and Language Disorders
2001 - 2003	Casey Merit Scholar, Baylor University
2000 - 2003	Dean's Academic Honor List, Baylor University
1999 - 2003	Presidential Scholar, Baylor University

Professional Memberships

Orodental Ontologies for Reporting Radiotherapy-induced Adverse sequeLae (O2R2AL) Consortium

2023 - Present

MD Anderson Cancer Center Image-Guided Cancer Therapy (IGCT) Research Program

2022 - Present

Head and Neck Cancer International Group (HNCIG)

2021 - Present

Head and Neck Cancer Alliance Board

2020 - 2022

Dysphagia Research Society - Early Research Career Development Committee

2020 - Present

Head and Neck Alliance, Inc

2020 - 2023

International Consortium for Health Outcomes (ICHOM) Head and Neck

2018 - Present

International Head and Neck Scientific Group

2017 - Present

NRG Oncology Head and Neck Core Committee

2016 - 2022

National Foundation of Swallowing Disorders (NFOSD)

2014 - Present

American Board of Swallowing and Swallowing Disorders

2014 - Present

Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology

2013 - Present

American Cancer Society Head & Neck Cancer Clinical Survivorship Care Guidelines Development Workgroup

2012 - Present

American Head and Neck Society

2012 - 2014

American Speech-Language-Hearing Association

2004 - Present

Texas Speech-Language-Hearing Association

2004 - Present

Houston Association for Communication Disorders

2004 - Present

Selected Publications

Peer-Reviewed Articles

Salama V, Humbert-Vidan L, Godinich B, Wahid KA, El-Habashy DM, Naser MA, He R, R Mohamed AS, Sahli AJ, Hutcheson KA, Gunn GB, Rosenthal DI, Fuller CD, Moreno AC. Machine learning predicting acute pain and opioid dose in radiation treated oropharyngeal cancer patients. Frontiers in Pain Research 6, 2025.
West NA, Attia SK, Kaffey Z, Dede C, Mulder SL, El-Habashy DM, Neuberger R, Naser MA, Frank SJ, Mao S, McMillan H, Smith B, Rosenthal D, Lai SY, Hutcheson KA, Moreno AC, Fuller CD. Evaluating observer reliability and diagnostic accuracy of CT-LEFAT criteria for post-treatment head and neck lymphedema: A prospective blinded comparative analysis. Oral Oncol 164:107265, 2025. e-Pub 2025. PMID: 40174310.
Sahin O, Kamel S, Wahid KA, Dede C, Taku N, He R, Naser MA, Sharafi CS, Makitie A, Kann BH, Kaski K, Sahlsten J, Jaskari J, Amit M, Chronowski GM, Diaz EM Jr, Garden AS, Goepfert RP, Guenette JP, Gunn GB, Hirvonen J, Hoebers F, Hutcheson KA, Guha-Thakurta N, Johnson J, Kaya D, Khanpara SD, Nyman K, Lai SY, Lango M, Learned KO, Lee A, Lewis CM, Maniakas A, Moreno AC, Myers JN, Phan J, Pytynia KB, Rosenthal DI, Sandulache VC, Schellingerhout D, Shah SJ, Sikora AG, Mohamed ASR, Chen MM, Fuller CD. International multispecialty expert physician preoperative identification of extranodal extension in patients with oropharyngeal cancer using computed tomography: Prospective blinded human inter-observer performance evaluation. Cancer 131(7):e35815, 2025. e-Pub 2025. PMID: 40159431.
Korivi BR, Warneke CL, Shehata MA, Buoy S, Tang X, Patnana M, Palmquist SM, Javadi S, Rao SP, Rauch RA, Wang MX, Elsayes KM, Hutcheson KA. Fluoroscopy Time of Radiologist-Monitored Modified Barium Swallow Exams in Oncology: A 3-year Single Institution Retrospective Study. Dysphagia, 2025. e-Pub 2025. PMID: 40156643.
Humbert-Vidan L, Castelo AH, He R, van Dijk LV, Rhee DJ, Wang C, Wang HC, Wahid KA, Joshi S, Gerafian P, West N, Kaffey Z, Mirbahaeddin S, Curiel J, Acharya S, Shekha A, Oderinde P, Ali AMS, Hope A, Watson E, Wesson-Aponte R, Frank SJ, Barbon CEA, Brock KK, Chambers MS, Walji M, Hutcheson KA, Lai SY, Fuller CD, Naser MA, Moreno AC. Image-based Mandibular and Maxillary Parcellation and Annotation using Computer Tomography (IMPACT): A Deep Learning-based Clinical Tool for Orodental Dose Estimation and Osteoradionecrosis Assessment. medRxiv, 2025. e-Pub 2025. PMID: 40166584.
de Vette SPM, van Rijn-Dekker MI, Van den Bosch L, Keijzer K, Neh H, Chu H, Li Y, Frederiks ML, van der Laan HP, Heukelom J, van Luijk P, van der Schaaf A, Steenbakkers RJHM, Sijtsema NM, Hutcheson KA, Fuller CD, Langendijk JA, Moreno AC, van Dijk LV. Evaluation of a comprehensive set of normal tissue complication probability models for patients with head and neck cancer in an international cohort. Oral Oncol 163:107224, 2025. e-Pub 2025. PMID: 40023984.
Eisenga JB, McCullough KB, Banwait JK, George TJ, Hutcheson KA, Smith RL, DiMaio JM, Schaffer JM. Enhanced Survival With Surgical Ablation of Atrial Fibrillation During Mitral Valve Surgery. Ann Thorac Surg, 2025. e-Pub 2025. PMID: 39952581.
McMillan H, Warneke CL, Buoy S, Porsche C, Savage K, Lai SY, Fuller CD, Hutcheson KA. Manual Therapy for Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors: The MANTLE Nonrandomized Clinical Trial. JAMA Otolaryngol Head Neck Surg, 2025. e-Pub 2025. PMID: 39913160.
Rigert J, Kaffey Z, Belal Z, Tripuraneni L, Humbert-Vidan L, Sahli A, Attia S, Hutcheson KA, Watson E, Hope A, Dede C, Kiat-Amnuay S, Walji M, Mohamed ASR, Sandulache VC, Fuller CD, Lai SY, Moreno A. Early Imaging Identification of Osteoradionecrosis and Classification Using the Novel ClinRad System: Results from A Retrospective Observational Cohort. medRxiv, 2025. e-Pub 2025. PMID: 39974112.
Ebersole BM, Chapman J, Warneke CL, Buoy S, Tang X, McMillan H, Aldridge E, Barbon CEA, Hutcheson KA. Compensatory Swallowing Strategies Recommended in Oncology Practice: Practice Patterns and Relationship to Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) Grades. Dysphagia, 2025. e-Pub 2025. PMID: 39827333.
Moreno AC, Watson EE, Humbert-Vidan L, Peterson DE, van Dijk LV, Urbano TG, Van den Bosch L, Hope AJ, Katz MS, Hoebers FJP, Wesson RAA, Bates JE, Bossi P, Dayo AF, Dore M, Fregnani ER, Galloway TJ, Gelblum DY, Hanna IA, Henson CE, Kiat-Amnuay S, Korfage A, Lee NY, Lewis CM, Lynggaard CD, Makitie AA, Magalhaes M, Mowery YM, Munoz-Montplet C, Myers JN, Orlandi E, Patel J, Rigert JM, Saunders D, Schoenfeld JD, Selek U, Somay E, Takiar V, Thariat J, Verduijn GM, Villa A, West N, Witjes MJH, Won A, Wong ME, Yao CMKL, Young SW, Al-Eryani K, Barbon CEA, Buurman DJM, Dieleman FJ, Hofstede TM, Khan AA, Otun AO, Robinson JC, Hum L, Johansen J, Lalla R, Lin A, Patel V, Shaw RJ, Chambers MS, Ma D, Singh M, Yarom N, Mohamed ASR, Hutcheson KA, Lai SY, Fuller CD. International Expert-Based Consensus Definition, Classification Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Inter-Disciplinary Modified Delphi Study. Int J Radiat Oncol Biol Phys, 2025. e-Pub 2025. PMID: 39826846.
Mao S, Wang J, McMillan H, Mohamed ASR, Buoy S, Ahmed S, Mulder SL, Naser MA, He R, Wahid KA, Chen MM, Ding Y, Moreno AC, Lai SY, Fuller CD, Hutcheson KA. Exploring Quantitative MRI Biomarkers of Head and Neck Post-Radiation Lymphedema and Fibrosis: Post Hoc Analysis of a Prospective Trial. Head Neck, 2025. e-Pub 2025. PMID: 39794912.
Nader ME, Choi J, Hernandez M, Hutcheson K, Myers T, Jivani S, Pratihar R, Fernandez K, Phan J, You C, Gidley PW. The Effects of Metformin on Cisplatin-Induced Ototoxicity in Diabetic Patients. Otolaryngol Head Neck Surg 172(1):243-253, 2025. e-Pub 2025. PMID: 39460639.
Shinn, EH, Garden, AS, Chen, M, Basen-Engquist, KM, Fellman, B, Hutcheson, KA, Morrison, WH, Peterson, SK, Li, L. Self-management intervention improves patient adherence to swallowing exercises during radiation for head and neck cancer. Head and Neck 46(11):2878-2889, 2024. e-Pub 2024. PMID: 38873861.
O'Hara JT, Hurt CN, Ingarfield K, Patterson JM, Hutcheson KA, Canham JE, Nixon LS, Heiberg CD, Johson S, Evans M, Jones TM. Transoral Laser or Robotic Surgery Outcomes for Oropharyngeal Carcinoma. JAMA Otolaryngology–Head & Neck Surgery, 2024. e-Pub 2024.
Donohue C, Croft K, Maristela SA, Folsom M, Hutcheson KA, Plowman EK. Preliminary Normative Reference Values of Validated FEES Scales in Healthy Young Adults. Laryngoscope, 2024. e-Pub 2024. PMID: 39390642.
McCullough KA, Eisenga JB, Banwait JK, Gasparini A, Harrington KB, George TJ, Hutcheson KA, Smith RL 2nd, Brinkman WT, DiMaio JM, Schaffer JM. Hospital and Surgeon Surgical Valvar Volume and Survival after Multi-Valve Cardiac Surgery in Medicare Beneficiaries. J Thorac Cardiovasc Surg, 2024. e-Pub 2024. PMID: 39243959.
Barbon CEA, Warneke CL, Ledger B, Rogus-Pulia N, Cunningham L, Coyle JL, Levesque-Boissonneault C, Alvarez C, Valencia D, Hutcheson KA. Reliability and Confidence of Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) Rating Among Research and Clinical Speech Pathologists Before and After Implementation of a Training Manual: A Multi-site Study. Dysphagia, 2024. e-Pub 2024. PMID: 39181934.
Humbert-Vidan L, Kamel S, Wentzel A, Kaffey Z, Abdelaal M, Spier KB, West NA, Marai GE, Canahuate G, Zhang X, Chen MM, Wahid KA, Rigert J, Hosseinian S, Schaefer AJ, Brock KK, Chambers M, Otun AO, Aponte-Wesson R, Patel V, Hope A, Phan J, Garden AS, Frank SJ, Morrison WH, Spiotto MT, Rosenthal D, Lee A, He R, Naser MA, Watson E, Hutcheson KA, Mohamed ASR, Sandulache VC, van Dijk LV, Moreno AC, Guerrero Urbano T, Lai SY, Fuller CD. Mandibular dose-volume predicts time-to-osteoradionecrosis in an actuarial normal-tissue complication probability (NTCP) model: External validation of right-censored clinico-dosimetric and competing risk application across international multi-institutional observational cohorts and online graphical user interface clinical support tool assessment. medRxiv, 2024. e-Pub 2024. PMID: 39228724.
Borders JC, Grande AA, Barbon CEA, Hutcheson KA, Troche MS. Effects of Statistical Practices for Longitudinal Group Comparison of the Penetration-Aspiration Scale on Power and Effect Size Estimation: A Monte Carlo Simulation Study. Dysphagia, 2024. e-Pub 2024. PMID: 39153045.
Manduchi, B, Fitch, MI, Ringash, J, Howell, D, Hutcheson, KA, Martino, R. Exploring the Acceptability of Behavioral Swallowing Interventions for Head and Neck Cancer Patients During Radiotherapy. Dysphagia 39(4):593-607, 2024. e-Pub 2024. PMID: 37991659.
Islam S, Gleber-Netto FO, Mulcahy CF, Glaun MDE, Srivastava S, Hunt PJ, Williams MD, Barbon CE, Spiotto M, Zhao W, Adebayo A, Akhter S, Xie T, Debnath KC, Sathishkumar HN, Myers B, Lothumalla S, Yaman I, Burks JK, Gomez J, Rao X, Wang J, Woodman K, Mansour J, Arenkiel B, Osman KL, Haxton C, Lever TE, Hutcheson KA, Amit M. Neural landscape is associated with functional outcomes in irradiated patients with oropharyngeal squamous cell carcinoma. Sci Transl Med 16(758):eabq5585, 2024. e-Pub 2024. PMID: 39083586.
Islam, S, Gleber-Netto, FO, Mulcahy, CF, Glaun, MD, Srivastava, S, Hunt, PJ, Williams, MD, Barbon, CE, Spiotto, MT, Zhao, W, Adebayo, A, Akhter, S, Xie, T, Debnath, KC, Sathishkumar, HN, Myers, B, Lothumalla, S, Yaman, I, Burks, JK, Gomez, JA, Rao, X, Wang, J, Woodman, K, Mansour, J, Arenkiel, BR, Osman, KL, Haxton, C, Lever, TE, Hutcheson, KA, Amit, M. Neural landscape is associated with functional outcomes in irradiated patients with oropharyngeal squamous cell carcinoma. Science translational medicine 16(758):eabq5585, 2024. e-Pub 2024. PMID: 39083586.
Hutcheson KA, Aldridge EF, Warneke CL, Buoy SN, Tang X, Macdonald C, Alvarez CP, Barringer DA, Barbon CEA, Ebersole BM, McMillan H, Montealegre JR. Clinical Implementation of DIGEST as an Evidence-Based Practice Tool for Videofluoroscopy in Oncology: A Six-Year Single Institution Implementation Evaluation. Dysphagia, 2024. e-Pub 2024. PMID: 38935170.
Sahin O, Kamel S, Wahid KA, Dede C, Taku N, He R, Naser MA, Sharafi S, Makitie A, Kann BH, Kaski K, Sahlsten J, Jaskari J, Amit M, Chronowski GM, Diaz EM Jr, Garden AS, Goepfert RP, Guenette JP, Gunn GB, Hirvonen J, Hoebers F, Hutcheson KA, Guha-Thakurta N, Johnson J, Kaya D, Khanpara SD, Nyman K, Lai SY, Lango M, Learned KO, Lee A, Lewis CM, Maniakas A, Moreno AC, Myers JN, Phan J, Pytynia KB, Rosenthal DI, Sandulache VC, Schellingerhout D, Shah SJ, Sikora AG, Mohamed ASR, Chen MM, Fuller CD. International Multi-Specialty Expert Physician Preoperative Identification of Extranodal Extension n Oropharyngeal Cancer Patients using Computed Tomography: Prospective Blinded Human Inter-Observer Performance Evaluation. medRxiv, 2024. e-Pub 2024. PMID: 36865096.
Hutcheson KA, Hutcheson KA, Kamel S, Wahid KA, Dede C, Taku N, He R, Naser MA, Sharafi S, Mäkitie A, Kann BH, Kaski K, Sahlsten J, Jaskari J, Amit M, Chronowski GM, Diaz Jr EM, Garden AS, Goepfert RP, Guenette JP, Gunn G, Hirvonen J, Hoebers F, Hutcheson KA, Guha-Thakurta N, Johnson J, Kaya D, Khanpara SD, Nyman K, Lai SY, Lango M, Learned KO, Lee A, Lewis CM, Maniakas A, Moreno AC, Myers JN, Phan J, Pytynia KB, Rosenthal DI, Sandulache VC, Schellingerhout D, Shah SJ, Sikora AG, R Mohamed AS, Chen MM, Fuller CD. International Multi-Specialty Expert Physician Preoperative Identification of Extranodal Extension n Oropharyngeal Cancer Patients using Computed Tomography: Prospective Blinded Human Inter-Observer Performance Evaluation, 2024.
Manduchi, B, Fitch, MI, Ringash, J, Howell, D, Hutcheson, KA, Martino, R. The Acceptability of Behavioural Swallowing Interventions for Head and Neck Cancer Patients During Radiotherapy. Dysphagia 39(3):412-423, 2024. e-Pub 2024. PMID: 37914886.
Bhayani MK, Hutcheson KA. Considerations in Salvage Laryngectomy Reconstruction-To Flap or Not to Flap. JAMA Otolaryngol Head Neck Surg 150(6):499-501, 2024. e-Pub 2024. PMID: 38635278.
Anderson, BJ, Moreno, AC, Qing, Y, Lee, JJ, Johnson, FM, Lango, MN, Barbon, CE, Tripuraneni, L, Sahli, A, Piper, V, Gross, N, Fuller, C, Lai, SY, Myers, JN, Hutcheson, KA. Revisiting Feeding Tube Utilization in Oropharynx Cancer. Otolaryngology - Head and Neck Surgery (United States) 170(5):1319-1330, 2024. e-Pub 2024. PMID: 38353360.
Carlander, AF, Bendtsen, SK, Rasmussen, JH, Jakobsen, KK, Garset-Zamani, M, Grønhøj, C, Friborg, J, Hutcheson, KA, Johnson, FM, Fuller, C, Moreno, AC, Babarinde, T, Gross, N, Myers, JN, von Buchwald, C. Clinical and prognostic differences in oropharyngeal squamous cell carcinoma in USA and Denmark, two HPV high-prevalence areas. European Journal of Cancer 202, 2024. e-Pub 2024. PMID: 38452723.
Hansen, NJ, Woodman, K, Buoy, S, Mao, S, Barbon, CE, Lai, SY, Fuller, C, Hutcheson, KA, Sanchez, B. Tongue electrical impedance myography correlates with functional, neurophysiologic, and clinical outcome measures in long-term oropharyngeal cancer survivors with and without hypoglossal neuropathy. Head and Neck 46(3):581-591, 2024. e-Pub 2024. PMID: 38133080.
Hansen NJ, Woodman K, Buoy S, Mao S, A Barbon CE, Lai SY, Fuller C, Hutcheson KA, Sanchez B. Tongue electrical impedance myography correlates with functional, neurophysiologic, and clinical outcome measures in long-term oropharyngeal cancer survivors with and without hypoglossal neuropathy: An exploratory study. Head and Neck 46(3):581-591, 2024.
Salama V, Humbert-Vidan L, Godinich B, Wahid KA, ElHabashy DM, Naser MA, He R, Mohamed ASR, Sahli AJ, Hutcheson KA, Gunn GB, Rosenthal DI, Fuller CD, Moreno AC. Comparison of Machine Leaning Models for Prediction of Acute Pain Severity and On-Treatment Opioid Utilization in Oral Cavity and Oropharyngeal Cancer Patients Receiving Radiation Therapy: Exploratory Analysis from a Large-Scale Retrospective Cohort. medRxiv, 2024. e-Pub 2024. PMID: 38370746.
Shinn, EH, Garden, AS, Peterson, SK, Leupi, DJ, Chen, M, Blau, R, Becerra, L, Rafeedi, T, Ramírez, J, Rodriquez, D, VanFossen, F, Zehner, S, Mercier, PP, Wang, J, Hutcheson, KA, Hanna, EY, Lipomi, DJ. Iterative Patient Testing of a Stimuli-Responsive Swallowing Activity Sensor to Promote Extended User Engagement During the First Year After Radiation. JMIR Cancer 10, 2024. e-Pub 2024. PMID: 38416544.
Noh, S, Bertini, CD, Mira-Avendano, I, Kaous, M, Patel, B, Faiz, S, Shannon, VR, Balachandran, D, Bashoura, L, Adachi, R, Evans, S, Dickey, BF, Wu, CC, Shroff, G, Manzano, JM, Granwehr, BP, Holloway, S, Dickson, KB, Mohammed, AD, Muthu, M, Song, H, Aroe, A, Aloia, TA, Lee Andrews, II, Badami, KK, Beird, H, Brock, K, Cata, JP, Dabaja, BS, Draetta, G, French, KE, Godoy, M, Hutcheson, KA, Jaffray, D, John, TM, Lee, JJ, Litton, J, McEnery, KW, Musunuru, TN, Nates, JL, Palaskas, NL, Ravi, V, Scheet, PA, Shete, S, Subbiah, IM, Tawbi, H, Woodman, SE, Chung, C, Khawaja, F, Sheshadri, A. Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer. Cancer medicine 12(17):17753-17765, 2023. e-Pub 2023. PMID: 37592894.
Salama, V, Youssef, S, Xu, T, Wahid, K, Chen, J, Rigert, J, Lee, A, Hutcheson, KA, Gunn, GB, Phan, JL, Garden, AS, Frank, SJ, Morrison, W, Reddy, JP, Spiotto, MT, Naser, M, Dede, C, He, R, Mohamed, AS, van Dijk, L, Lin, R, Roldan, C, Rosenthal, DI, Fuller, C, Moreno, AC. Temporal characterization of acute pain and toxicity kinetics during radiation therapy for head and neck cancer. A retrospective study. Oral Oncology Reports 7, 2023. e-Pub 2023. PMID: 38638130.
Dohopolski MJ, Diao K, Hutcheson KA, Akhave NS, Goepfert RP, He W, Lei XJ, Peterson SK, Shen Y, Sumer BD, Smith BD, Sher DJ. Long-term Patient-Reported Outcomes in a Population-Based Cohort Following Radiotherapy vs Surgery for Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg 149(8):697-707, 2023. e-Pub 2023. PMID: 37382943.
Starmer HM, Hutcheson K, Patterson J. Internal oedema and dysphagia characteristics in patients with head and neck cancer. Clin Otolaryngol 48(4):700-704, 2023. e-Pub 2023. PMID: 36918287.
Shinn EH, Garden AS, Peterson SK, Leupi DJ, Chen M, Blau R, Becerra L, Rafeedi T, Ramirez J, Rodriquez D, VanFossen F, Zehner S, Mercier P, Wang J, Hutcheson K, Hanna E, Lipomi D. Iterative patient testing of a stimuli-responsive swallowing activity sensor to promote extended user engagement during the first year after radiation, 2023. e-Pub 2023.
Hutcheson KA, Starmer H. Letter to the Editor re: Intra and interobserver agreement of the Dynamic Imaging Grade of Swallowing Toxicity Scale (DIGEST) in fiberoptic endoscopic evaluation of swallowing (FEES): the importance of observer-tailored training. Eur Arch Otorhinolaryngol 280(6):3045-3046, 2023. e-Pub 2023. PMID: 36912933.
Williams LA, Whisenant MS, Mendoza TR, Peek AE, Malveaux D, Griffin DK, Ponce DA, Granwehr BP, Sheshadri A, Hutcheson KA, Ali SM, Peterson SK, Heymach JV, Cleeland CS, Subbiah IM. Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID). J Patient Rep Outcomes 7(1):48, 2023. e-Pub 2023. PMID: 37237077.
Reddy, DS, Cuenca, JA, Botdorf, JS, Muthu, M, Hanmandlu, A, Wegner, RC, Crommett, JW, Gutierrez, C, Rathi, N, Sajith, B, Knafl, M, Abbas, HA, Woodman, SE, Nates, JL, Aaroe, AE, Aloia, TA, Andrews, L, Badami, KK, Baganz, JA, Bajwa, P, Baker, LR, Barbosa, GR, Beird, H, Bourgeois, M, Brock, K, Burton, EM, Cata, JP, Chung, C, Cutherell, M, Dabaja, BS, Draetta, G, French, KE, Futreal, A, Gibbons, C, Godoy, M, Gunther, J, Hutcheson, KA, Jaffray, D, John, TM, Lee, JJ, Litton, J, McEnery, KW, Palaskas, NL, Ravi, V, Scheet, PA, Schmidt, S, Subbiah, IM, Tawbi, H, Wu, J, Yao, JC. Clinical Characteristics and Cause of Death Among Hospitalized Decedents With Cancer and COVID-19. Mayo Clinic Proceedings 98(3):451-457, 2023. e-Pub 2023. PMID: 36868753.
Shih E, George TJ, DiMaio JM, Squiers JJ, Banwait JK, Hutcheson KA, Smith RL, Ryan WH. Contemporary Outcomes of Isolated Tricuspid Valve Surgery. J Surg Res 283:1-8, 2023. e-Pub 2023. PMID: 36334576.
Hemmati M, Barbon C, Mohamed ASR, van Dijk LV, Moreno AC, Gross ND, Goepfert RP, Lai SY, Hutcheson KA, Schaefer AJ, Fuller CD. Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity. Cancer Med 12(4):5088-5098, 2023. e-Pub 2023. PMID: 36229990.
Wentzel, A, Mohamed, AS, Naser, M, van Dijk, L, Hutcheson, KA, Moreno, AC, Fuller, C, Canahuate, GM, Marai, EG. Multi-organ spatial stratification of 3-D dose distributions improves risk prediction of long-term self-reported severe symptoms in oropharyngeal cancer patients receiving radiotherapy. Frontiers in Oncology 13, 2023. e-Pub 2023. PMID: 37614495.
Rodriguez, V, Greco, E, Theurer, J, Mills, G, Hutcheson, KA, Martino, R. The Development of a Standardized Videofluoroscopic Swallow Study Barium Mixing Protocol. Canadian Journal of Speech-Language Pathology and Audiology 47(1):67-77, 2023. e-Pub 2023.
Watson LJ, Woodman SH, Ganderton D, Hutcheson KA, Pringle S, Patterson JM. Development of the remote 100 ml Water Swallow Test versus clinical assessment in head and neck cancer patients: do they agree?. Head & Neck 44(12):2769-2778, 2022. e-Pub 2022. PMID: 36114683.
Contrera KJ, Zafereo ME, Yaniv D, Roberts DB, Gillenwater AM, Hanna EY, Weber RS, Myers JN, Chang EI, Garvey PB, Hanasono MM, Yu P, Hutcheson KA, Fuller CD, Tyler MA, Neskey DM. Outcomes for recurrent oral cavity squamous cell carcinoma. Oral Oncol 134:106127, 2022. e-Pub 2022. PMID: 36155359.
Das P, Maiti R, Komal M, Hutcheson KA, Fuller CD, Chakraborty B, Peterson C. Estimating the optimal linear combination of predictors using spherically constrained optimization. Biometrics, 2022. e-Pub 2022. PMID: 36261805.
Barbon CEA, Yao CMK, Peterson CB, Moreno AC, Goepfert RP, Johnson FM, Chronowski GM, Fuller CD, Gross ND, Hutcheson KA. Swallowing After Primary TORS and Unilateral or Bilateral Radiation for Low- to Intermediate-Risk Tonsil Cancer. Otolaryngol Head Neck Surg 167(3):1945998211059967, 2022. e-Pub 2022. PMID: 34784256.
Martino R, Khan M, Fitch M, Manduchi B, Rodriguez V, Hutcheson KA, Barbon C, McMillan H. Exploring Patient Experiences with a Telehealth Approach for the PRO-ACTIVE Trial Intervention in Head and Neck Cancer Patients. BMC Health Services Research 22(1):1218, 2022. e-Pub 2022. PMID: 36180905.
Aggarwal P, Hutcheson KA, Yu R, Wang J, Fuller CD, Garden AS, Goepfert RP, Rigert J, Mott FE, Lu C, Lai SY, Gunn GB, Chambers MS, Li G, Wu CC, Hanna EY, Sturgis EM, Shete S. Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors. Scientific Reports, 2022. e-Pub 2022. PMID: 35459784.
Ding Y, Meheissen MAM, Zhou K, Mohamed ASR, Wen Z, Ping NG S, Elhalawani, HM, Elgohari BA, Hutcheson, KA, Chung C, Lai SY, Fuller CD. Evaluation of different diffusion-weighted image techniques for head and neck radiation treatment: phantom and volunteer studies. Practical Radiation Oncology, 2022. e-Pub 2022.
Hutcheson KA, Barbon CEA, Alvarez C, Warneke C. Refining Measurement of Swallowing Safety in the Dynamic Safety Grade of Swallowing Toxicity (DIGEST) Criteria: Validation of DIGEST Version 2. Cancer, 2022. e-Pub 2022. PMID: 34985765.
Wahid, K, He, R, McDonald, B, Anderson, BM, Salzillo, TC, Mulder, SL, Wang, J, Sharafi, CS, McCoy, L, Naser, M, Ahmed, S, Sanders, KL, Mohamed, AS, Ding, Y, Wang, J, Hutcheson, KA, Lai, SY, Fuller, C, van Dijk, L. Intensity standardization methods in magnetic resonance imaging of head and neck cancer. Physics and Imaging in Radiation Oncology 20:88-93, 2021. e-Pub 2021. PMID: 34849414.
Martino R, Fitch MI, Fuller CD, Hope AJ, Krisciunas GP, Lanmore S, Lazarus C, Macdonald CL, McCulloch TM, Mills G, Palma D, Pytynia KB, Ringash J, Sultanem K, Theurer J, Thorpe KE, Hutcheson KA. The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVention for patients receiving radiotherapy for head and neck cancer. BMC Cancer 21, 2021. e-Pub 2021. PMID: 34645411.
Aggarwal P, Hutcheson KA, Garden AS, Mott FE, LU Charles LU, Goepfert R, Fuller CD, Lai SY, Gunn GB, Chambers MS, Sturgis EM, Hanna EY, Shete S. Determinants of patient-reported xerostomia among long-term oropharyngeal survivors. Cancer Medicine, 2021. e-Pub 2021. PMID: 34358341.
Hutcheson K, McMillan H, Warneke C, Porsche C, Savage K, Buoy S, Wang J, Woodman K, Lai S, Fuller C. Manual Therapy for Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors: The Pilot MANTLE Trial. BMJ Open 11(8), 2021. e-Pub 2021. PMID: 34348950.
Bahig H, Gunn GB, Garden AS, Ye R, Hutcheson KA, Rosenthal DI, Phan J, Fuller DC, Morrison WH, Reddy JP, NG SP, Gross ND, Sturgis EM, Ferrarotto R, Gillison M, Frank SJ. Patient-reported Outcomes after Oropharynx Intensity Modulated Proton Therapy using Functional Assessment of Cancer Therapy-Head and Neck Instrument. International Journal of Particle Therapy 1:213-222, 2021. e-Pub 2021. PMID: 34285948.
Starmer H, Arrese L, Langmore S, Ma Y, Murray J, Patterson J, Pisegna J, Roe J, Tabor-Gray L, Hutcheson KA. Adaptation and Validation of the Dynamic Imaging Grade of Swallowing Toxicity for Flexible Endoscopic Evaluation of Swallowing DIGEST FEES. Journal of Speech, Language, and Hearing Research 64(6):1802-1810, 2021. e-Pub 2021. PMID: 34033498.
Elhalawani H, Cardena CE, Volpe S, Barua S, Stieb S, Rock C, Lin T, Yang P, Wu H, Zaveri J, Elgohari B, Abdallag LE, Am J, Mohamed ASR, Court LE, Hutcheson KA, Gunn GB, Rosenthal DI, Frank S, Garden AS, Rao A, Fuller CD. 18FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancer. Clinical and Translational Radiation Oncology 29:93-101, 2021. e-Pub 2021. PMID: 34195391.
Gunn GB, Garden AS, Ausat N, Dahlstrom KR, Morrison WH, Fuller CD, Phan J, Reddy JP, Shah SJ, Mayo LL, Chun SG, Chronowski GM, Moreno AC, Myers JN, Hanna EY, Esmaeli B, Gillison ML, Ferrarotto R, Hutcheson KA, Chambers MS, Ginsberg LE, El-Naggar AK, Rosenthal DI, Zhu XR, Frank SJ. Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience. Int J Part Ther 8(1):108-118, 2021. e-Pub 2021. PMID: 34285940.
Hernandez M, Lee JJ, Yap B, Ye R, Foote RL, Busse P, Patel SH, Dagan R, Snider J, Mohammed N, Lin A, Blanchard P, Cantor SB, Teferra MY, Hutcheson KA, Yepes P, Mohan R, Liao Z, DeLaney T, Frank SJ. The Reality of Randomized Controlled Trials for Assessing the Benefit of Proton Therapy: Critically Examining the Intent-to-Treat Principle in the Presence of Insurance Denial. Advances in Radiation Oncology, 2021. e-Pub 2021. PMID: 33732960.
Barua S, Elhalawani H, Volpe S, Al Feghali KA, Yang P, Ng SP, Elgohari B, Mackin DS, Gunn GB, Hutcheson KA, Chambers MS, Court LE, Mohamed AS, Fuller CD, Lai SY, Rao A. Computed Tomography radiomics kinetics as early imaging correlates of osteoradionecrosis in oropharyngeal cancer patients. Frontiers Artificial Intelligence 9(4), 2021. e-Pub 2021. PMID: 33898983.
Bahig H, Rosenthal DI, Nguyen-Tan FP, Fuller DC, Yuan Y, Hutcheson KA, Christopoulos A, Nichols AC, Fung K, Ballivy O, Filion E, Ng SP, Lambert L, Dorth J, Hu KS, Palma D. Vocal-cord Only vs. Complete Laryngeal radiation (VOCAL): a randomized multicentric Bayesian phase II trial. BMC Cancer 21(1):446, 2021. e-Pub 2021. PMID: 33888069.
Aggarwal P, Goepfert RP, Garden AS Garg N, Zaveri JS, Du XL, Swartz MD, Lai SY, Fuller CD, Ferrarotto R, Sturgis EM, Piller LB, Hutcheson KA. Risk and Clinical Risk Factors Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Squamous Cell Carcinoma Survivors. JAMA Otolaryngology, 2021. e-Pub 2021. PMID: 33538759.
Wahid K, He R, McDonald BA, Anderson BA, Salzillo T, Mulder S, Wang J, Sharafi CS, McCoy L, Naser MA, Ahmed S, Sanders KL, Mohamed ASR, Ding Y, Wang J, Hutcheson KA, Lai SY, Fuller CD, can Dijik LV. MRI Intensity Standardization Evaluation Design for Head and Neck Quantitative Imaging Applications. Medrxiv, 2021. e-Pub 2021.
Mott FE, Sacks RL, Johnson FM, Hutcheson, KA, Gallagher NA, Varghese S, Zaveri J. Subjective Functional Outcomes in Oropharyngeal Cancer Treated with Induction Chemotherapy using the MD Anderson Symptom Inventory (MDASI). Laryngoscope Investigative Otolaryngology 6(5):1104-1109, 2020. e-Pub 2020. PMID: 33364400.
Kamal M, Mohamed ASR, Fuller CD, Sturgis EM, Johnson FM, Morrison WH, Gunn GB, Hutcheson KA, Phan J, Volpe S, Ng SP, Phan J, Cardenas C, Ferrarotto R, Frank SJ, Rosenthal DI, Garden AS. Patterns of Failure After Intensity Modulated Radiation Therapy in Head and Neck Squamous Cell Carcinoma of Unknown Primary: Implication of Elective Nodal and Mucosal Dose Coverage. Adv Radiat Oncol 5(5):929-935, 2020. e-Pub 2020. PMID: 33083655.
Hutcheson KA, Gomes A, Rodriguez V, Barringer D, Khan M, Martino R. Eat All Through Radiation Therapy (EAT-RT): Structured therapy model to facilitate continued oral intake through head and neck radiotherapy-User acceptance and content validation. Head Neck 42(9):2390-2396, 2020. e-Pub 2020. PMID: 32445231.
Grant SR, Hutcheson KA, Ye R, Garden AS, Morrison WH, Rosenthal DI, Gunn GB, Fuller CD, Phan J, Reddy JP, Moreno AC, Lewin JS, Sturgis EM, Ferrarotto R, Frank SJ. Prospective Longitudinal Patient-Reported Outcomes of Swallowing Following Intensity Modulated Proton Therapy for Oropharyngeal Cancer. International Journal of Radiation Oncology • Biology • Physics, 2020. e-Pub 2020. PMID: 32361662.
van Diks L, Ventura JD, Wahid, KA, Z LL, Mcdonald B, Ahmed SM, Sanders K, Stieb SM, McCoy LA, Sharafi CS, Preston KE, Ding Y, Wang J, Rigaud BS, Sen A, Chambers MS, Hutcheson KA, Brock K, Lai SY, Mohamed ASR. Black bone MRI morphometry for mandibular cortical bone measurement in head and neck cancer patients: a method comparison with CT. Radiology, 2020. e-Pub 2020.
Jomaa MK, Crosby R, Grant S, Granberry RC, O'Donnel B, Dursteler A, Warren BW, Volpe S, Al Feghali K, Cardenas CE, Cardoso R, Lai SY, Radwan AS, Fuller CD, Hutcheson KA. Dose-Volume correlates of the prevalence of patient-reported trismus in long-term survivorship after oropharyngeal IMRT: A cross-sectional dosimetric analysis. Radiotherapy and Oncology:142-149, 2020. e-Pub 2020. PMID: 32387489.
Garden AS, Kamal MJ, Mohamed AR, Frank SJ, Lewin JS, Lai SY, Morrison WH, Phan J, Ferrarotto R, Rosental DI, Hutcheson KA, Fuller CD, Gunn GB. Neurologic Sequelae of Treatment of Oropharyngeal Cancer: A Patient Reported Outcomes Study. Journal of Clinical Oncology, 2020. e-Pub 2020. PMID: 32212359.
Jomaa M, Fuller CD, Gunn GB, Hutcheson KA, Mohamed ASR, Peeler CR, Cardenas CE, Yepes P, Amit J, Frank SJ, Mirkovic D, Blanchard P, Chen L, Breiner B, Mehta VN. Radiation-induced hypothyroidism after radical intensity-modulated radiation therapy for oropharyngeal carcinoma. Advances in Radiation Oncology 5(1):111-119, 2020. e-Pub 2020. PMID: 32051897.
He R, Ding Y, Mohamed ASR, Ng SP, Ger RB, Elhalawani H, Elgohari BA, Young KH, Hutcheson KA, Fuller CD, Lai SY. Simultaneously spatial and temporal higher-order total variations for noise suppression and motion reduction in DCE and IVIM. Proc SPIE Int Soc Opt Eng 11313, 2020. e-Pub 2020. PMID: 32753776.
Mohamed ASR, Smith BD, Smith JB, Sevak P, Malek JS, Kanwar A, Browne T, Gunn GB, Garden AS, Frank SJ, Morrison WH, Phan J, Zafereo M, Skinner H, Lai SY, Hutcheson KA, Lewin JS, Hessel AE, Thekdi AA, Weber RS, Fuller CD, Rosenthal DI. Outcomes of carotid-sparing IMRT for T1 glottic cancer: comparison with conventional radiation. Laryngoscope 130(1):1-8, 2020. e-Pub 2020. PMID: 30756394.
Yang J, Mohamed ASR, Bahig H, Ding Y, Wang J, Ng SP, Lai S, Miller A, Hutcheson KA, Fuller CD, Development Cooperative JHANRM. Automatic registration of 2D MR cine images for swallowing motion estimation. PLOS One 15(2):e0228652, 2020. e-Pub 2020. PMID: 32045464.
Check DK, Hutcheson KA, Poisson LM, Pocobelli G, Sakoda LC, Zaveri J, Chang SS, Chubak J. Factors associated with employment discontinuation among older and working age survivors of oropharyngeal cancer. Head Neck 41(11):3948-3959, 2019. e-Pub 2019. PMID: 31490588.
Hutcheson KA, Warneke CL, CMKL Y, Zaveri J, Elgohari BE, Goepfert R, Hessel AC, Kupferman ME, Lai SY, Fuller CD, Gunn GB, Garden AS, Johnson F, Ferrarotto R, Lewin JS, Gross ND, MD Anderson Head and Neck Cancer Symptom Working Group MD. Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg 145(11):1053-1063, 2019. e-Pub 2019. PMID: 31556933.
Pocobelli G, Ziebell R, Fujii M, Hutcheson KA, Chang S, McClure JB, Chubak J. Symptom Burden in Long-Term Survivors of Head and Neck Cancer: Patient-Reported Versus Clinical Data. EGEMS (Wash DC) 7(1):25, 2019. e-Pub 2019. PMID: 31328132.
Hamandi M, Smith RL, Ryan WH, Grayburn PA, Vasudevan A, George TJ, DiMaio JM, Hutcheson KA, Brinkman W, Szerlip M, Moore DO, Mack MJ. Outcomes of Isolated Tricuspid Valve Surgery Have Improved in the Modern Era. Ann Thorac Surg 108(1):11-15, 2019. e-Pub 2019. PMID: 30951698.
Omari T, Ciucci M, Gozdzikowska K, Hernandez E, Hutcheson K, Jones C, Maclean J, Nativ-Zeltzer N, Plowman E, Rogus-Pulia N, Rommel N, O'Rourke A. High resolution pharyngeal manometry: protocols and metrics recommendations of the high resolution pharyngeal manometry international working group. Dysphagia, 2019. e-Pub 2019. PMID: 31168756.
Christopherson K, Ghosh A, Mohamed ASR, Jomaa MK, Gunn B, Marai CE, Canahuate G, El Halawani H, Vock D, Kalpathy-Cramer J, Dale T, Messer J, Garden AS, Frank SJ, Lewin JS, Lai SY, Morrison WH, Phan J, Gross N, Ferrarotto R, Weber RS, Rosenthal DI, Hutcheson KA, Fuller D. Chronic Radiation-Associated Dysphagia in Oropharyngeal Cancer Survivors: Towards Age-Adjusted Dose Constraints for Deglutitive Muscles. Clinical and Translationsal Radiation Oncology, 2019. e-Pub 2019. PMID: 31341972.
Grant S, Kamal M, Mohamed ASR, Zaveri J, Barrow MP, Gunn GB, Lai SY, Lewin JS, Rosenthal DI, Wang XS, Fuller CD, Hutcheson KA. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing. Cancer 125(10):1654-1664, 2019. e-Pub 2019. PMID: 30633325.
Kamal M, Rosenthal DI, Batra AD, Volpe S, Elgohari B, Goepfert RP, Garden AS, Hutcheson KA, Phan J, Eraj S, Dursteler A, Williams B, Smith J, Aymard J, Berends J, White A, Cardenas CE, Frank SJ, Morrison WH, Sturgis EM, Mendoza TR, Mohamed AS, Fuller CD, Gunn GB. Fatigue Following Radiation Therapy in Nasopharyngeal Cancer Survivors: A Dosimetric Analysis Incorporating Patient Report and Observer Rating. International Journal of Radiation Oncology 102(3):749-750, 2019. e-Pub 2019. PMID: 30935579.
Krisciunas GP, Vakharia A, Lazarus C, Taborda SG, Martino R, Hutcheson KA, McCulloch T, Langmore S. Application of manual therapy for dysphagia in head and neck cancer patients: a preliminary national survey of treatment trends and adverse events. Global Advances in Health and Medicine 8, 2019. e-Pub 2019. PMID: 31041144.
Massarelli E, Haddad RI, Lee JJ, Lin HY, Hutcheson KA, Lewis J, Garden AS, Blumenschein Jr GR, Jr W, WN, Pharaon RR, Tishler RB, Glisson BS, Gold KA, Johnson FM, Rabinowits G, Ginsberg LE, Williams MD, Myers JN, Kies MS, Papadimitrakopoulou V. Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by risk-based local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma. Annals of Oncology, 2019. e-Pub 2019. PMID: 30596812.
Hutcheson KA, Gomes A, Rodriguez V, Barringer D, Khan M, Martino R. EAT All Through Radiation Therapy (EAT-RT): Structured therapy model to facilitate continued oral intake through head and neck radiotherapy- User acceptance and content validation. Dysphagia 34:944-1018, 2019. e-Pub 2019. PMID: 32445231.
Moran A, Hutcheson KA, Zaveri J, Lewin JS, Kupferman M, Hessel A, Goepfert R, Gunn B, Garden A, Ferrarotto R, Fuller C, Tam S, Gross N. Patient-Reported Outcomes of Symptom Burden in Patients Receiving Surgical or Nonsurgical Treatment for Low-Intermediate Risk Oropharyngeal Squamous Cell Carcinoma: A Comparative Analysis of a Prospective Registry. Oral Oncology 91:13-20, 2019. e-Pub 2019. PMID: 30926057.
Hutcheson KA, Nurgalieva Z, Zhao H, Gunn GB, Giordano SH, Bhayani MK, Lewin JS, Lewis CM. Two-year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER-Medicare analysis. Head Neck 41(2):479-487, 2019. e-Pub 2019. PMID: 30536748.
Meheissen MAM, Mohamed ASR, Kamal M, Hernandez M, Volpe S, Elhalawani H, Barrow MP, Ding Y, Wang J, Davuluri R, Rostom Y, Hegazy N, Gunn GB, Lai SY, Garden AS, Lewin JS, Rosenthal DI, Frank SJ, Fuller CD, Hutcheson KA, Development Cooperative JHANR. A prospective longitudinal assessment of MRI signal intensity kinetics of non-target muscles in patients with advanced stage oropharyngeal cancer in relationship to radiotherapy dose and post-treatment radiation-associated dysphagia: Preliminary findings from a randomized trial. Radiotherapy and Oncology, 2019. e-Pub 2019. PMID: 30206020.
Bahig H, Yuan Y, Mohamed A, Brock K, Wang J, Ding Y, McCulloch M, van den Berg C, Ng SP, Oelfke U, Terhaard C, Balter P, Fuller C, Li AX, Karam I, Philippens M, Gunn BG, Sonke JJ, van der Heide U, Harrington K, Bhide S, Doornaert P, Rosenthal DI, Aristophanous M, Raaijmakers C, Frank S, Al-Mamgani A, Blanchard P, Garcia J, Phan J, Blinde S, Lai S, Heukelom J, Hutcheson K, Awan M, Cazoulat G, Robbins J, Garden A, Newbold K, McPartlin A, Nutting C, McSpadden K. Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL Stage 2a-2b/ Bayesian Phase II Trial. Clin Trans Radiat Oncol 13:19-23, 2018. e-Pub 2018. PMID: 30386824.
Grossberg AJ, Mohamed ASR, Elhalawani H, Bennett WC, Smith KE, Nolan TS, Williams B, Chamchod S, Heukelom J, Kantor ME, Browne T, Hutcheson KA, Gunn GB, Garden AS, Morrison WH, Frank SJ, Rosenthal DI, Freymann JB, Fuller CD. Author Correction: Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy. Sci Data 5(1):1, 2018. e-Pub 2018. PMID: 30482902.
Cardoso, RC, Qazali A, Zaveri J, Chambers MS, Gunn GB, Fuller CD, Lai SY, Mott FE, Hutcheson KA. Self-reported oral morbidities in long-term oropharyngeal cancer survivors: a cross-sectional survey of 906 survivors. Oral Onc(88-94), 2018. e-Pub 2018. PMID: 30115482.
Kamal M, Mohamed ASR, Volpe S, Zaveri J, Portwood Barrow M, Gunn GB, Lai SY, Lewin JS, Rosenthal DI, Jethanandani AMeheissen AM, Mulder SL, Cardenas CE, Fuller CD, Hutcheson KA. Radiotherapy dose-volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: Results of a prospective registry. Radiother Oncol 3:442-451, 2018. e-Pub 2018. PMID: 29961581.
Aggarwal P, Zaveri J, Goepfert R, Shi Q, Du X, Swartz M, Gunn GB, Lai SY, Fuller CD, Hanna EY, Rosenthal DI, Lewin JS, Piller LB, Hutcheson KA. Symptom burden associated with late lower cranial neuropathy in long-term oropharyngeal cancer survivors. JAMA Otolaryngol Head Neck Surg, 2018. e-Pub 2018. PMID: 30193299.
Kamal M, Barrow P, Lewin JS, Estrella A, Gunn GB, Shi Q, Hofstede TM, Rosenthal DI, Fuller CD, Hutcheson KA. Modeling symptom drivers of oral intake in long-term head and neck cancer survivors. Support Care Cancer, 2018. e-Pub 2018. PMID: 30218187.
Ng SP, Bahig H, Wang J, Cardenas CE, Lucci A, Hall CS, Meas S, Sarli VN, Yuan Y, Urbauer DL, Ding Y, Ikner S, Dinh V, Elgohari BA, Johnson JM, Skinner HD, Gunn GB, Garden AS, Phan J, Rosenthal DI, Morrison WH, Frank SJ, Hutcheson KA, Mohamed ASR, Lai SY, Ferrarotto R, MacManus MP, Fuller CD. Predicting treatment response based on dual assessment of magnetic resonance imaging kinetics and circulating tumor cells in patients with head and neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling. BMC Cancer 18(1), 2018. e-Pub 2018. PMID: 30231854.
Grossberg AJ, Mohamed ASR, El Halawani H, Bennett WC, Smith KE, Nolan TS, Williams B, Chamchod S, Heukelom J, Kantor ME, Browne T, Hutcheson KA, Gunn GB, Garden AS, Morrison WH, Frank SJ, Rosenthal DI, Freymann JB, Fuller CD. Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy. Sci Data 5:180173, 2018. e-Pub 2018. PMID: 30179230.
Hutcheson KA, Barrow MP, Warneke CL, Wang Y, Eapen G, Lai SY, Barringer DA, Plowman EK, Lewin JS. Cough strength and expiratory force in aspirating and nonaspirating postradiation head and neck cancer survivors. Laryngoscope 128(7):1615-1621, 2018. e-Pub 2018. PMID: 29114887.
Hutcheson KA, Barrow MP, Plowman EK, Lai SY, Fuller CD, Barringer DA, Eapen G, Wang Y, Hubbard R, Jimenez SK, Little LG, Lewin JS. Expiratory muscle strength training for radiation-associated aspiration after head and neck cancer: a case-series. Laryngoscope 128(5):1044-1051, 2018. e-Pub 2018. PMID: 28833185.
Bahig H, Aristophanous M, Blanchard P, Kamal M, Ding Y, Cardena C, Brock K, Lai SY, Hutcheson KA, Phan J, Wang J, Ibbott G, Gabr R, Narayana P, Garden A, Rosenthal D, Gunn GB, Fuller CD. Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT. Clin Transl Radiat Oncol, 2018. e-Pub 2018. PMID: 30014042.
Goepfert RP, Lewin JS, Barrow MP, Warneke CL, Fuller CD, Lai SY, Weber RS, Hutcheson KA. Grading dysphagia as a toxicity of head and neck cancer: differences in severity classification based on MBS DIGEST and clinical CTCAE grades. Dysphagia 33(2):185-191, 2018. e-Pub 2018. PMID: 28836005.
Kamal M, Mohamed ASR, Fuller CD, Sturgis EM, Johnson FM, Morrison WH, Gunn GB, Hutcheson KA, Phan J, Volpe S, Ng SP, Ferrarotto R, Frank SJ, Skinner HD, Rosenthal DI, Garden AS. Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity modulated radiation therapy. Cancer 124(7):1415-1427, 2018. e-Pub 2018. PMID: 29338089.
Frank SJ, Blanchard P, Lee J, Sturgis EM, Kies MS, Machtay M, Vikram B, Garden AS, Rosenthal DI, Gunn GB, Fuller CD, Hutcheson KA, Lai SY, Busse PM, Lee NY, Lin A, Foote RL. Comparing intensity-modulated proton therapy with intensity-modulated photon therapy for oropharyngeal cancer: the journey from clinical trial concept to activation. Sem Radiat Onc 28(2):108-113, 2018. e-Pub 2018. PMID: 29735186.
Kamal M, Ng SP, Eraj SA, Rock CD, Pham B, Messer JA, Garden AS, Morrison WH, Phan J, Frank SJ, El-Naggar AK, Johnson JM, Ginsberg LE, Ferrarotto R, Lewin JS, Hutcheson KA, Cardenas CE, Zafereo ME, Lai SY, Hessel AC, Weber RS, Gunn GB, Fuller CD, Mohamed ASR, Rosenthal DI. Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer. Oral Oncol 79:1-8, 2018. e-Pub 2018. PMID: 29598944.
Kamal M, Rosenthal DI, Volpe S, Goepfert RP, Garden AS, Hutcheson KA, Al Feghali KA, Meheissen MAM, Eraj SA, Dursteler AE, Williams B, Smith JB, Aymard JM, Berends J, White AL, Frank SJ, Morrison WH, Cardoso R, Chambers MS, Sturgis EM, Mendoza TR, Lu C, Mohamed ASR, Fuller CD, Gunn GB, MD Anderson Head and Neck Cancer Symptom Working Group MD. Patient reported dry mouth: instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors. Radiother Oncol 126(1):75-80, 2018. e-Pub 2018. PMID: 29229507.
Goepfert RP, Fuller CD, Gunn GB, Hanna EY, Lewin JS, Zaveri JS, Hubbard RM, Barrow MP, Hutcheson KA. Symptom burden as a driver of decisional regret in long-term oropharyngeal carcinoma survivors. Head Neck 39(11):2151-2158, 2017. e-Pub 2017. PMID: 28736965.
MD Anderson Head and Neck Cancer Symptom Working Group MD, Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymard JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Brandon Gunn G. Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65 years old. Radiat Oncol 12(1):186, 2017. e-Pub 2017. PMID: 29169353.
Hansen CC, Smith JB, Mohamed ASR, Mulcahy CF, Wefel JS, Hutcheson KA, Chrane K, Phan J, Frank SJ, Garden AS, Smith BD, Eichelberger H, Anderson C, McCoy C, Horiates M, Patrick C, Floris S, French C, Beadle BM, Morrison WH, Su SY, Lewis CM, Kupferman ME, Johnson JM, Skinner HD, Lai SY, Hanna EY, Rosenthal DI, Fuller CD, Gunn GB, MD Anderson Head and Neck Cancer Symptom Working Group MD. Cognitive function and patient-reported memory problems after radiotherapy for cancers at the skull base: A cross-sectional survivorship study using the Telephone Interview for Cognitive Status and the MD Anderson Symptom Inventory-Head and Neck Module. Head Neck 39(10):2048-2056, 2017. e-Pub 2017. PMID: 28763137.
Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymar JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Gunn GB, MD Anderson Head and Neck Cancer Symptom Working Group MD. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old. Radiat Oncol 12(1):150, 2017. e-Pub 2017. PMID: 28888224.
Mohamed ASR, Song J, Hutcheson K, Murri M, Garg N, Hobbs B, Gunn GB, Sandulache V Beadle B, Phan J, Morrison WH, Frank SJ, Blanchard P, Garden AS, El-Halawani H, Jomaa MK, Chambers M, Lewin J, Ferraroto R, Zhu R, Zhang X, Hofstede T, Cardoso RC, Gillenwater AM, Sturgis E, Weber R, Rosenthal DI, Fuller CD, Lai SY. Dose-volume correlates of mandibular osteoradionecrosis in oropharynx cancer patients receiving intensity-modulated radiotherapy: results from a case-matched comparison. Radiother Oncol:232-239, 2017. e-Pub 2017. PMID: 28733053.
Hutcheson KA, Yuk M, Hubbard R, Gunn GB, Fuller CD, Lai SY, Lin H, Garden AS, Rosenthal DI, Hanna EY, Kies MS, Lewin JS. Delayed lower cranial neuropathy after oropharyngeal intensity-modulated radiotherapy: A cohort analysis and literature review. Head Neck 39(8):1516-1523, 2017. e-Pub 2017. PMID: 28452175.
Shiao JC, Mohamed ASR, Messer JA, Hutcheson KA, Johnson JM, Enderling H, Kamal M, Warren BW, Pham B, Morrison WH, Zafereo ME, Hessel AC, Lai SY, Kies MS, Ferrarotto R, Garden AS, Schomer DF, Gunn GB, Phan J, Frank SJ, Beadle BM, Weber RS, Lewin JS, Rosenthal DI, Fuller CD. Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx. Head Neck 39(8):1609-1620, 2017. e-Pub 2017. PMID: 28464542.
Zhang W, Zhang X, Yang P, Blanchard P, Garden AS, Gunn B, Fuller CD, Chambers M, Hutcheson KA, Ye R, Lai SY, Radwan MAS, Zhu XR, Frank SJ. Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer. Radiother Oncol 123(3):401-405, 2017. e-Pub 2017. PMID: 28549794.
Goepfert RP, Hutcheson KA, Lewin JS, Desai NG, Zafereo ME, Hessel AC, Lewis CM, Weber RS, Gross ND. Complications, hospital length of stay, and readmission after total laryngectomy. Cancer 123(10):1760-1767, 2017. e-Pub 2017. PMID: 28026864.
Goepfert RP, Lewin JS, Barrow MP, Fuller CD, Lai SY, Song J, Hobbs BP, Gunn GB, Beadle BM, Rosenthal DI, Garden AS, Kies MS, Papadimitrakopoulou VA, Schwartz DL, Hutcheson KA. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma. Laryngoscope 127(4):842-848, 2017. e-Pub 2017. PMID: 27440393.
Hutcheson KA, Hammer MJ, Rosen SP, Jones CA, McCulloch TM. Expiratory muscle strength training evaluated with simultaneous high-resolution manometry and electromyography. Laryngoscope 127(4):797-804, 2017. e-Pub 2017. PMID: 28083946.
Goepfert RP, Lewin JS, Barrow MP, Gunn GB, Fuller CD, Beadle BM, Garden AS, Rosenthal DI, Kies MS, Papadimitrakopoulou V, Lai SY, Gross ND, Schwartz DL, Hutcheson KA. Long-term prospective performance of the M. D. Anderson Dysphagia Inventory in "low-intermediate risk" oropharyngeal carcinoma after intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 97(4):700-708, 2017. e-Pub 2017. PMID: 27485284.
Sheu T, Vock D, Gross N, Mulcahy C, Zafereo M, Gunn G, Garden A, Sevak P, Phan J, Lewin J, Frank S, Beadle B, Morrison W, Lai S, Hutcheson KA, Marai GE, Canahuate GM, Kies M, El-Naggar A, Weber R, Rosenthal D, Fuller CD, Working Group MLC. Conditional survival analysis of patients with locally advanced laryngeal cancer: construction of a dynamic risk model and clinical nomogram. Sci Rep 7:43928, 2017. e-Pub 2017.
Wong AT, Lai SY, Gunn GB, Beadle BM, Fuller CD, Barrow MP, Hofstede TM, Chambers MS, Sturgis EM, Mohamed AS, Lewin JS, Hutcheson KA. Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: a cohort analysis. Oral Oncol 66:75-80, 2017. e-Pub 2017. PMID: 28249651.
Hutcheson KA, Barrow MP, Barringer DA, Knott JK, Lin HY, Weber RS, Fuller CD, Lai SY, Alvarez CP, Raut J, Lazarus CL, May A, Patterson J, Roe JW, Starmer HM, Lewin JS. Dynamic imaging grade of swallowing toxicity (DIGEST): scale development and validation. Cancer 123(1):62-70, 2017. e-Pub 2017. PMID: 27564246.
Somogyi-Ganss E, Chambers MS, Lewin JS, Tarrand JJ, Hutcheson KA. Biofilm on the tracheoesophageal voice prosthesis: considerations for oral decontamination. Eur Arch Otorhinolaryngol 274(1):405-413, 2017. e-Pub 2017. PMID: 27400694.
Chen DW, Lewin JS, Xu L, Lai SY, Gunn GB, Fuller CD, Mohamed AS, Kanwar A, Sturgis EM, Hutcheson KA. Feeding tube utilization in patients with salivary gland malignancies. Otolaryngol Head Neck Surg 156(1):109-117, 2017. e-Pub 2017. PMID: 27576681.
Lewin JS, Baumgart LM, Barrow MP, Hutcheson KA. Device life of the tracheoesophageal voice prosthesis revisited. JAMA Otolaryngol Head Neck Surg 143(1):65-71, 2017. e-Pub 2017. PMID: 27684464.
Beadle BM, Liao KP, Giordano SH, Garden AS, Hutcheson KA, Lai SY, Guadagnolo BA. Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis. Cancer 123(2):283-293, 2017. e-Pub 2017. PMID: 27662641.
Gitomer SA, Hutcheson KA, Christianson BL, Samuelson MB, Barringer DA, Roberts DB, Hessel AC, Weber RS, Lewin JS, Zafereo ME. Influence of timing, radiation, and reconstruction on complications and speech outcomes with tracheoesophageal puncture. Head Neck 38(12):1765-1771, 2016. e-Pub 2016. PMID: 27394060.
Fuller CD, Mohamed AS, Garden AS, Gunn GB, Mulcahy CF, Zafereo M, Phan J, Lai SY, Lewin JS, Hutcheson KA, Frank SJ, Beadle BM, Morrison WH, El-Naggar AK, Kocak-Uzel E, Ginsberg LE, Kies MS, Weber RS, Rosenthal DI. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches. Head Neck 38(12):1739-1751, 2016. e-Pub 2016. PMID: 27466789.
Phan J, Sio TT, Nguyen TP, Takiar V, Gunn GB, Garden AS, Rosenthal DI, Fuller CD, Morrison WH, Beadle B, Ma D, Zafereo ME, Hutcheson KA, Kupferman ME, William WN, Frank SJ. Reirradiation of head and neck cancers with proton therapy: outcomes and analyses. Int J Radiat Oncol Biol Phys 96(1):30.41, 2016. e-Pub 2016. PMID: 27325480.
Blanchard P, Garden AS, Gunn GB, Rosenthal DI, Morrison WH, Hernandez M, Crutison J, Lee JJ, Ye R, Fuller CD, Mohamed AS, Hutcheson KA, Holliday EB, Thaker NG, Sturgis EM, Kies MS, Zhu XR, Mohan R, Frank SJ. Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis. Radiother Oncol 120(1):48-55, 2016. e-Pub 2016. PMID: 27342249.
Hutcheson KA, Abualsamh AR, Sosa A, Weber RS, Beadle BM, Sturgis EM, Lewin JS. Impact of selective neck dissection on chronic dysphagia after chemo-intensity-modulated radiotherapy for oropharyngeal carcinoma. Head Neck 38(6):886-893, 2016. e-Pub 2016. PMID: 26339764.
Tucker JR, Xu L, Sturgis EM, Mohamed AS, Hofstede TM, Chambers MS, Lai SY, Fuller CD, Beadle B, Gunn GB, Hutcheson KA. Osteoradionecrosis in patients with salivary gland malignancies. Oral Oncol 57:1-5, 2016. e-Pub 2016. PMID: 27208837.
Grossberg AJ, Chamchod S, Fuller CD, Mohamed AS, Heukelom J, Eichelberger H, Kantor ME, Hutcheson KA, Gunn GB, Garden AS, Frank S, Phan J, Beadle B, Skinner HD, Morrison WH, Rosenthal DI. Association of body composition with survival and locoregional control of radiotherapy-treated head and neck squamous cell carcinoma. JAMA Oncol 2(6):782-9, 2016. e-Pub 2016. PMID: 26891703.
Hutcheson KA, Barrow MP, Lisec A, Barringer DA, Gries K, Lewin JS. What is a clinically relevant difference in MDADI scores between groups of head and neck cancer patients?. Laryngoscope 126(5):1108-13, 2016. e-Pub 2016. PMID: 26542529.
Gunn GB, Blanchard P, Garden AS, Zhu XR, Fuller CD, Mohamed AS, Morrison WH, Phan J, Beadle BM, Skinner HD, Sturgis EM, Kies MS, Hutcheson KA, Rosenthal DI, Mohan R, Gillin MT, Frank SJ. Clinical outcomes and patterns of disease recurrence after intensity modulated proton therapy for oropharyngeal squamous carcinoma. Int J Radiat Oncol Biol Phys 95(1):360-7, 2016. e-Pub 2016. PMID: 27084653.
Lewis CM, Aloia TA, Shi W, Martin I, Lai SY, Selber JC, Hessel AC, Hanasono MM, Hutcheson KA, Robb GL, Weber RS. Development and feasibility of a specialty-specific national surgical quality improvement program (NSQIP): The head and neck-reconstructive surgery NSQIP. JAMA Otolaryngol Head Neck Surg 142(4):321-327, 2016. e-Pub 2016. PMID: 26892756.
Sandulache VC, Vandelaar LJ, Skinner HD, Cata J, Hutcheson K, Fuller CD, Phan J, Siddiqui Z, Lai SY, Weber RS, Zafereo ME. Salvage total laryngectomy after external-beam radiotherapy: A 20-year experience. Head Neck 38 Suppl 1:E1962-8, 2016. e-Pub 2016. PMID: 26879395.
Takiar V, Ma D, Garden AS, Li J, Rosenthal DI, Beadle BM, Frank SJ, Fuller CD, Gunn GB, Morrison WH, Hutcheson K, El-Naggar AK, Gold KA, Kupferman ME, Phan J. Disease control and toxicity outcomes for T4 carcinoma of the nasopharynx treated with intensity-modulated radiotherapy. Head Neck 38 Suppl 1:E925-33, 2016. e-Pub 2016. PMID: 25994561.
Messer JA, Mohamed AS, Hutcheson KA, Ding Y, Lewin JS, Wang J, Lai SY, Frank SJ, Garden AS, Sandulache V, Eichelberger H, French CC, Colen RR, Phan J, Kalpathy-Cramer J, Hazle JD, Rosenthal DI, Gunn GB, Fuller CD. Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: longitudinal dose-response characterization of quantitative signal kinetics. Radiother Oncol 118(2):315-22, 2016. e-Pub 2016. PMID: 26830697.
Dale T, Hutcheson KA, Mohamed, AS, Lewin JS, Gunn GB, Rao AU, Kalpathy-Cramer J, Frank SJ, Garden AS, Messer JA, Warren B, Lai SY, Morrison WH, Phan J, Skinner H, Gross N, Ferrarotto R, Weber R, Rosenthal DI, Fuller CD. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy. Radiother Oncol 118(2):304-314, 2016. e-Pub 2016. PMID: 26897515.
Sandulache VC, Hobbs BP, Mohamed ASR, Frank SJ, Song J, Ding Y, Kalpathy-Cramer J, Hazle JD, Wang J, Awan M, Rosenthal DI, Garden AS, Gunn GB, Colen RR, El-shafeey N, El-banan M, Hutcheson KA, Lewin J, Chambers MS, Hofstede T, Weber RS, Lai SY, Fuller CD. Dynamic contrast-enhanced MRI detects acute radiotherapy-induced alterations in mandibular microvasculature: prospective assessment of imaging biomarkers of normal tissue injury. Sci Rpt 6:29864, 2016. e-Pub 2016. PMID: 27499209.
Gunn GB, Hansen CC, Garden AS, Fuller CD, Mohamed AS, Morrison WH, Frank SJ, Beadle BM, Phan J, Chronowski GM, Sturgis EM, Lewis CM, Lu C, Hutcheson KA, Mendoza TR, Cleeland CS, Rosenthal DI. Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa: Results from a symptom assessment study. Radiother Oncol 117(1):132-138, 2015. e-Pub 2015. PMID: 26403258.
Owadally W, Hurt C, Timmins H, Parsons E, Townsend S, Patterson J, Hutcheson KA, Powerll N, Beasley M, Palaniappan N, Robinson M, Jones TM, Evans M. PATHOS: A phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for human papillomavirus (HPV) - positive oropharyngeal cancer. BMC Cancer 15(1):602, 2015. e-Pub 2015. PMID: 26311526.
Holliday EB, Garden AS, Rosenthal DI, Fuller CD, Morrison WH, Gunn BG, Phan J, Beadle BM, Zhu XR, Zhang X, Hanna E, Glisson BS, Hutcheson KA, El-Naggar AK, Hong J, Hung T, Uzel EK, Lewis G, Frank SJ. Proton therapy reduces treatment-related toxicities for patients with nasopharyngeal cancer: a case-match control study of intensity-modulated proton therapy and intensity-modulated photon therapy. IJPT 2(1):19-28, 2015. e-Pub 2015.
Hutcheson KA, Yuk MM, Holsinger FC, Gunn GB, Lewin JS. Late radiation-associated dysphagia (late-RAD) with lower cranial neuropathy in long-term oropharyngeal cancer survivors: video case reports. Head Neck 37(4):E56-62, 2015. e-Pub 2015. PMID: 25043608.
Hutcheson KA, Holsinger FC, Kupferman ME, Lewin JS. Functional outcomes after TORS for oropharyngeal cancer: A systematic review. Eur Arch Otorhinolaryngol 272(2):463-471, 2015. e-Pub 2015. PMID: 24643851.
Smith BG, Hutcheson KA, Little LG, Skoracki RJ, Rosenthal DI, Lai SY, Lewin JS. Lymphedema outcomes in patients with head and neck cancer. Otolaryngol Head Neck Surg 152(2):284-291, 2015. e-Pub 2015. PMID: 25389318.
Setton J, Lee NY, Riaz N, Huang SH, Waldron J, O'Sullivan B, Zhang Z, Shi W, Rosenthal DI, Hutcheson KA, Garden AS. A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy. Cancer 121(2):294-301, 2015. e-Pub 2015. PMID: 25286832.
Awan MJ, Mohamed AS, Lewin JS, Baron CA, Gunn GB, Rosenthal DI, Holsinger FC, Schwartz DL, Fuller CD, Hutcheson KA. Late radiation-associated dysphagia (late-RAD) with lower cranial neuropathy after oropharyngeal radiotherapy: A preliminary dosimetric comparison. Oral Oncol 50(8):746-52, 2014. e-Pub 2014. PMID: 24906528.
Lewin JS, Portwood MA, Wang Y, Hutcheson KA. Clinical application of the Provox NiD voice prosthesis: A longitudinal study. Laryngoscope 124(7):1585-1591, 2014. e-Pub 2014. PMID: 24352975.
Rosenthal DI, Mendoza TR, Fuller CD, Hutcheson KA, Wang XS, Hanna EY, Lu C, Garden AS, Morrison WH, Cleeland CS, Gunn GB. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: A prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer 120(13):1975-84, 2014. e-Pub 2014. PMID: 24711162.
Hutcheson KA, Lewin JS, Holsinger FC, Steinhaus G, Lisec A, Barringer DA, Lin HY, Villalobos S, Garden AS, Papadimitrakopoulou V, Kies MS. Long-term functional and survival outcomes after induction chemotherapy and risk-based definitive therapy for locally advanced squamous cell carcinoma of the head and neck. Head Neck 36(4):474-80, 2014. e-Pub 2014. PMID: 23780650.
Avery RA, Hwang EI, Ishikawa H, Acosta MT, Hutcheson KA, Santos D, Zand DJ, Kilburn LB, Rosenbaum KN, Rood BR, Schuman JS, Packer RJ. Handheld optical coherence tomography during sedation in young children with optic pathway gliomas. JAMA Ophthalmol 132(3):265-71, 2014. e-Pub 2014. PMID: 24435762.
Shinn EH, Basen-Engquist K, Baum G, Steen S, Bauman RF, Morrison W, Garden AS, Sheil C, Kilgore K, Hutcheson KA, Barringer D, Yuan Y, Lewin JS. Adherence to preventive exercises and self-reported swallowing outcomes in post-radiation head and neck cancer patients. Head Neck 35(12):1707-12, 2013. e-Pub 2013. PMID: 24142523.
Bhayani MK, Hutcheson KA, Barringer DA, Lisec A, Alvarez CP, Roberts DB, Lai SY, Lewin JS. Gastrostomy tube placement in patients with hypopharyngeal cancer treated with radiotherapy or chemoradiotherapy: Factors affecting placement and dependence. Head Neck 35(11):1641-1646, 2013. e-Pub 2013. PMID: 23322563.
Hutcheson KA, Bhayani MK, Beadle BM, Gold KA, Shinn EH, Lai SY, Lewin J. Eat and exercise during radiotherapy or chemoradiotherapy for pharyngeal cancers: use it or lose it. JAMA Otolaryngol Head Neck Surg 139(11):1127-34, 2013. e-Pub 2013. PMID: 24051544.
Avery RA, Dombi E, Hutcheson KA, Acosta MT, Baldwin AM, Madigan WP, Gillespie A, Fitzgibbon EJ, Packer RJ, Widemann BC. Visual outcomes in children with neurofibromatosis type 1 and orbitotemporal plexiform neurofibromas. Am J Ophthalmol 155(6):1089-1094.e1, 2013. e-Pub 2013. PMID: 23453281.
Fingeret MC, Hutcheson KA, Jensen K, Yuan Y, Urbauer D, Lewin JS. Associations among speech, eating, and body image concerns for surgical patients with head and neck cancer. Head Neck 35(3):354-360, 2013. e-Pub 2013. PMID: 22431304.
Raol N, Hutcheson KA, Lewin JS, Kupferman ME. Surgical management of the non-functional larynx after organ preservation therapy. J Otol Rhinol 2(1), 2013. e-Pub 2013.

Invited Articles

Connelly K, Gurd L, Noll K, Prabhu S, Kumar V, Hutcheson KA. A Framework for Integrating Speech Language Pathology in an Interdisciplinary Awake Craniotomy Program for Brain Tumor Resection. Perspectives of The ASHA Special Interest Groups, 2022. e-Pub 2022.
Arrese LC, Hutcheson KA. Framework for Speech-Language Pathology Services in Patients with Oral Cavity and Oropharyngeal Cancers. Oral Maxillofac Surg Clin North Am 30(4):397-410, 2018. e-Pub 2018. PMID: 30266189.
Malandraki GA, Hutcheson KA. Intensive therapies for dysphagia: implementation of the intensive dysphagia rehabilitation and the M. D. Anderson bootcamp approach. ASHAWire, 2018. e-Pub 2018.
Hutcheson KA. Developing a clinical question into a research question: the “use it or lose it” example. Perspectives on Swallowing and Swallowing Disorders (Dysphagia) SIG 13(Volume 2, Part 4):147-154, 2017. e-Pub 2017.
Ciucci M, Jones CA, Malandraki GA, Hutcheson KA. Dysphagia practice in 2035: beyond fluorography, thickener, and electrical Stimulation. Semin Speech Lang 37(3):201-18, 2016. e-Pub 2016. PMID: 27232095.
Cohen EE, LaMonte SJ, Erb NL, Beckman KL, Sadeghi N, Hutcheson KA, Stubblefield MD, Abbott DM, Fisher PS, Stein KD, Lyman GH, Pratt-Chapman ML. American Cancer Society Head and Neck Cancer Survivorship Care Guideline. CA Cancer J Clin 66(3):203-39, 2016. e-Pub 2016. PMID: 27002678.
Lewis CM, Hutcheson KA, Kupferman ME. Comparative effectiveness in head and neck malignancies. Cancer Treat Res 164:89-99, 2015. e-Pub 2015. PMID: 25677020.
Hutcheson KA, Lewin JS. Functional assessment and rehabilitation - How to maximize outcomes. Otolaryngol Clin North Am 46(4):657-70, 2013. e-Pub 2013. PMID: 23910476.
Hutcheson, KA. Late radiation-associated dysphagia (RAD) in head and neck cancer survivors. Perspectives on Swallowing and Swallowing Disorders (Dysphagia) 22(2):61-72, 2013. e-Pub 2013.

Manuals, Teaching Aids, Other Teaching Publications

Tutt, Hutcheson B(, Katherine). Therapy Preserves Swallowing Function (Interview for MD Anderson Cancer Center publication). Oncolog, 2018.
Tutt, Hutcheson B(, Katherine). Reports from the Survivorship Research Symposium: Expiratory Muscle Exercise Reduces Aspiration in Head and Neck Cancer Survivors (Interview for MD Anderson Cancer Center publication). Oncolog 62(4):6-8, 2017.
Hutcheson KA. MedBridge: Be Proactive! A Best Practice Guide for Treating Radiation-Associated Dysphagia. MedBridge, 2017.
Tutt, Hutcheson B(, Katherine). Swallowing Therapy Improves Function and Quality of Life for Patients with Head and Neck Cancer. (Interview for MD Anderson Cancer Center publication). Oncolog 61(2):5-6, 2016.
Hutcheson (Contributor) KA. News from SPOHNC (Support for People with Oral and Head and Neck Cancer): Start Swallowing, Eating ASAP in Oral Cancer Therapy, 2013.
web publication) HK(IFMA. Cancer Frontline: Eating and Swallowing Exercises During Treatment Benefit Cancer Patients Later. Houston, Texas, 2013.
and consultant) HK(. MD Anderson Cancer Center (Houston) Swallowing Boot Camp. National Foundation of Swallowing Disorders (NFOSD) website, 2013.
Hutcheson KA. Is the leak through or AROUND your voice prosthesis?, 2011.
Hutcheson KA. Respiratory Muscle Strength Training.

Editorials

Squiers JJ, Hutcheson KA, Thatcher JE, DiMaio JM. Cardiac stem cell therapy: checkered past, promising future?. J Thorac Cardiovasc Surg 148(6):3188-93, 2014. PMID: 25433891.

Abstracts

Dharmarathna I, Gandhi P, Panes V, Barbon CEA, Steele CM, Hutcheson KA. A Comparison of PixelBased Measures of Bolus Clearance and DIGEST Efficiency Ratings. 32nd Meeting of the Dysphagia Research Society, 2024. e-Pub 2024.
Tang, X, Warneke C, Buoy S, Barbon CEA, Macdonald C, Hutcheson KA. Clinical Implementation and Integration of Evidence-Based Practice Tools in Real-World Modified Barium Swallow Studies. Dysphagia Research Society Meeting (DRS). e-Pub 2024.
Mao S, Sahli AJ, Buoy SN, Gelabert GA, Barbon CE, Naser MA, Fuller C, Brock KK, Hutcheson KA. Automated Classification of Food Bolus Types in Modified Barium Swallowing Studies Using Deep Learning: Towards Automated DIGEST Grading. e-Pub 2024.
Mao S, Sahli AJ, Buoy SN, Gelabert GA, Barbon CE, Naser MA, Fuller C, Brock KK, Hutcheson KA. Deep Learning-Based Classification of Normal and Impaired Swallowing Using the DIGEST Framework: A Preliminary Analysis. Dysphagia Research Society Meeting (DRS). e-Pub 2024.
Hutcheson KA, Aldridge E, Warneke C, Buoy SN, Tang X, Barringer DA, Barbon CEA, Ebersole B, McMillan H, Alvarez C, Montealegre J. Clinical Implementation of DIGEST as an Evidence-Based Practice Tool for Videofluroscopy in Oncology: A Six- Year Single Institution Implementation Evaluation in 13,670 Swallow Studies. Dysphagia Research Society Meeting (DRS), 2024. e-Pub 2024.
Borders JC, Grande AA, Barbon, CEA, Hutcheson KA, Troche MS. Effects of Statistical Practices for Longitudinal Group Comparison of the PenetrationAspiration Scale on Power and Effect Size Estimation: A Monte Carlo Simulation Study. 31st Meeting of the Dysphagia Research Society, 2024. e-Pub 2024.
Manduchi B, Fitch MI, Ringash J, Howell D, Hutcheson KA, Martino R. Experiences of SpeechLanguage Pathologists providing swallowing interventions for Head and Neck Cancer during Radiotherapy as part of the PRO-ACTIVE Clinical Trial. Dysphagia Research Society Meeting (DRS), 2024. e-Pub 2024.
Ebersole B, Ferrarotto R, Sui D, Lee J, Diaz Jr E, Rosenthal DI, Hutcheson KA. Preliminary Analysis of Laryngeal Organ Function after Single Modality Chemo/immunotherapy for T2-T3 Laryngeal Tumors in the Phase II iCOLP Trial. Dysphagia Research Society Meeting (DRS), 2024. e-Pub 2024.
Levesque-Boissonneault C, Michaud M, Trepanier D, Dore S, Jacobs H, Lajeunesse ER, Tacqueniere S, Hutcheson KA, Caty M. French Canadian Linguistic and Cultural Adaptation of DIGEST V2 for Head and Neck Cancer Patients. Dysphagia Research Society Meeting (DRS), 2024. e-Pub 2024.
Martino R, Rodriguez V, Sabry A, Barbon CE, Hutcheson KA. Maintaining VFS Rating Skills Using a Continuous Audit and Targeted Refresher. Dysphagia Research Society Meeting (DRS), 2024. e-Pub 2024.
Burdick, R, Wu, J, Aldridge, E, Terp, C, Gustafson, S, Warneke, C, Rogus-Pulia, N, Hutcheson KA. Does Standardized Inclusion of Thickened Liquids in a Modified Barium Swallow Bolus Protocol Affect DIGEST Scores?. 32nd Meeting of the Dysphagia Research Society. e-Pub 2024.
Gillison M, Williams M, Johnson J, Leung C, Reddy J, Garden A, Ferrarotto R, Mott F, Le X, Gunn G, Lee Am Fuller C, Moreno A, Hutcheson K, Gross N, Lango M, Goepfert R, Myers J, Hanna E, Xiao W, Rudqvist NP, Lee J, Phan J. Phase 2 trial of induction and concomitant CTLA4 (ipilimumab) and PD-1 (nivolumab) immune checkpoint blockade and intensity modulated radiation therapy (IMRT) in HPV-positive oropharyngeal squamous cell carcinoma (HPV-OPSCC). Journal for ImmunoTherapy of Cancer 10(2), 2022. e-Pub 2022.
Hutcheson KA, Peterson C, Barbon CEA, Quon H, Mehra R, Ringash J, Lewin J, Flamand Y, Duvvuri U, Ozer E, Thomas G, Kupferman M, Kock W, Bell R, Saba N, Panwar A, Annino Jr D, Wagner L, Ferris R, Burtness B. Reduced aspiration rates for 50 Gy postoperative radiation in HPV-associated oropharynx cancer in E3311: a trial of the ECOG-ACRIN Cancer Research Group. Red Journal 114(3):S27-28, 2022. e-Pub 2022.
He R, Wahid K, Mohamed A, McDonald B, Ding Y, Nasser M, Wang J, Hutcheson KA, Fuller CD, Lai SY. Koopman Theory-Based Dynamic Mode Decomposition for Dynamic Contrast-Enhanced HNC MRI Motion Correction. American Association of Physicists in Medicine, 2022. e-Pub 2022.
Gilmore KR, Hutcheson KA, Chapman PH, Ryan WB, Goepfret R, Pytynia KB, Rodriguez MA. Symptom Profile of Head and Neck Patients Initiating Care in a Survivorship Clinic 40(16):e2047, 2022. e-Pub 2022.
McMillan H, Lewin JS, Cardoso R, Mayo L, Porsche C, Savage K, Barbon C, Buoy S, |Hutcheson KA. Manual Therapy For Head And Neck Cancer Related Trismus: A Case Series. Jama Otolaryngol Head Neck Surg 148(5):418-425, 2022. e-Pub 2022. PMID: 35297966.
Aggarwal P, Hutcheson KA, Garden AS, Mott F, Lu C, Goepfert RP, Fuller CD, Lai S, Gunn GB, Chambers MS, Sturgis EM, Hanna EY, Shete SS. Risk Factors of Patient-Reported Xerostomia Among Oropharyngeal Cancer Survivors Treated with Definitive Radiotherapy. Int J Radiat Oncol Biol Phys 111(3S):e160, 2021. e-Pub 2021. PMID: 34700812.
Wang J, McCoy L, Salama V, Dede C, Hutcheson KA, Fuller CD, van Dijk LV. Sub-Acute Post-Treatment Dysphagia and Shortness of Breath Symptoms Associate With Worse Survival in Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys 111(3S):e400-e401, 2021. e-Pub 2021. PMID: 34701366.
Barbon CE, Peterson CB, Fuller CD, Lai S, Moreno AC, Johnson FM, Hutcheson KA. Prospective Validation of the Use It or Lose It Paradigm: Secondary Analysis of Sub-Acute Dietary Outcomes by Eat and Exercise Status During Oropharyngeal Radiotherapy. Int J Radiat Oncol Biol Phys 111(3S):e408-e409, 2021. e-Pub 2021. PMID: 34701381.
Aggarawal P, Goepfert RP, Garden AS, Garg N, Zaveri J, Du XL, Swartz M, Lai SY, Fuller CD, Ferrarotto R, Piller L, KA &. Risk and Predictors of Late Lower Cranial Neuropathy In Long-Term Oropharyngeal Cancer Survivors: A Single Institution Retrospective Cohort Study Among 2,021 Survivors. Dysphagia, 2021. e-Pub 2021. PMID: 33538759.
Williams L, Whisenant M, Mendoza TR, Malveaux D, Griffin D, Ponce D, Cleeland CS, Peek A, Granwehr BP, Hutcheson KA, Shaw KR, Ravi V, Woodman SC, Chung C, Aloia TA, Futreal PA, Jaffray DA, Subbiah IM. Development and validation of a novel patient reported outcomes measure for symptom burden in patients with cancer and COVID-19 infection 36(15):12113, 2021. e-Pub 2021.
Deshpande TS, Gunn GB, Fuller CD, Ye R, Rosenthal DI, Garden AS, Morrison W, Phan J, Reddy J, Sturgis E, Lu C, Chambers M, Hutcheson K, Wang L, Zhang X, Zhu R, Stieb S, Foote R, Frank SJ. Erratum to: Xerostomia Impacts Dysgeusia in Oropharyngeal Cancer Patients Treated with Proton Therapy. International Journal of Radiation Oncology Biology and Physics:E414-E415, 2019. e-Pub 2019.
Bahig H, Gunn GB, Garden AS, Rosenthal DI, Hutcheson KA, Phan J, Fuller CD, Reddy JP, Rong Y, Zaveri H, Ng SP, Weber RS, Myers JN, Gross ND, Sturgis EM, Lu C, Gillison ML, Frank SJ. Toxicity and Pharyngeal Dysphagia Outcomes from Intensity Modulated Proton Therapy for Oropharyngeal Squamous Cell Cancer. International Journal Radiation Oncology Biology Physics 105(1):E410, 2019. e-Pub 2019.
Fitch M, Macdonald C, Hutcheson KA, McCulloch TM, Martino R. Engaging Stakeholders to Identify Relevant Outcomes For Dysphagia Interventions. Support Care Cancer:S168, 2019. e-Pub 2019.
Hutcheson KA, Zaveri J, Lewin JS, Fuller CD, Gunn GB, Ferrarotto R, Yao C, Gross ND. Evolution of postsurgical dysphagia after TORS for oropharyngeal cancer: A prospective registry analysis. Jama Otolaryngol Head Neck Surg, 2019. e-Pub 2019.
Hutcheson KA, Warneke C, Alvarez C, Barrringer D, J Knott J, Lewin JS. Reliability of “Real-Time” Grading of Dysphagia Severity (per DIGEST) by Speech Pathologists Conducting Videofluoroscopic Swallow Studies. Jama Otolaryngol Head Neck Surg, 2019. e-Pub 2019.
Hutcheson KA. Expiratory Muscle Strength Training (EMST) for Radiation-Associated Dysphagia (RAD): Results of a Pilot Prospective Trial. Dysphagia 34(6):995, 2019. e-Pub 2019.
Elhalawani H, Volpe S, Cardenas CE, Barua S, Rock C, Lin T, Yang P, Wu H, Zaveri J, Elgohari B, Abdallah LE, Jethanandani A, Mohamed AS, Hutcheson KA, Gunn GB, Rosenthal DI, Frank SJ, Garden AS, Rao A, Fuller CD. Development of Temporal Dose-Weighted Positron Emission Tomography Metabolic Imaging Biomarkers (PET MIBs) of Radiation-Related Parotid Glands Injury in Oropharyngeal Cancer Patients. International Journal of Radiation Oncology 102(3):240-241, 2018. e-Pub 2018.
Elgohari B, Mohamed AS, Ng SP, Elhalawani H, Elsayes AK, He R, Ding Y, Wang J, Elawadi M, Awad I, Hutcheson KA, Gunn BG, Frank SJ, Garden AS, Rosenthal DI, Lai S, Fuller CD. Diffusion-Weighted MRI As an Early Biomarker of Xerostomia in Oropharyngeal Cancer Patients Treated with Radiation Therapy. International Journal of Radiation Oncology 102(3):214-215, 2018. e-Pub 2018.
Aggarwal P, Zaveri J, Goepfert RP, Gunn GB, Lai S, Fuller CE, Hanna EY, Rosenthal DI, Lewin JS, Hutcheson KA. Functional Burden Associated with Late Lower Cranial Neuropathy in Long-Term Oropharyngeal Cancer Survivors Treated with Definitive Radiation Therapy. International Journal of Radiation Oncology 102(3):E408, 2018. e-Pub 2018.
Kamal M, Rosenthal DI, Volpe S, Goepfert RP, Garden AS, Hutcheson KA, Eraj S, Dursteler A, Williams B, Smith J, Aymard J, Berends J, White A, O'Donnell B, Frank SJ, Morrison WH, Cardoso R, Chambers MS, Sturgis EM, Mendoza TR, Cardenas CE, Skinner HD, Phan J, Mohamed AS, Fuller CD, Gunn GB. Patient-Reported Dry Mouth after Radiation Therapy for Head and Neck Cancer: Dosimetric Analysis of Long-Term Outcomes. International Journal of Radiation Oncology 102(3):e748, 2018. e-Pub 2018.
Mohamed AS, Al Feghali KA, Ng SP, Elhalawani H, Hutcheson KA, Chambers MS, Phan J, Kraeima J, Glas H, Witjes M, Gunn GB, Garden AS, Rosenthal DI, Frank SJ, Morrison WH, Fuller CD, Lai S. Investigation of the Three-Dimensional Dose Distribution of Mandibular Areas of Origin of Advanced Osteoradionecrosis in Oropharyngeal Cancer Patients Receiving IMRT. International Journal of Radiation Oncology 102(3):E335-336, 2018. e-Pub 2018.
Grant SR, Kamal M, Mohamed AS, Zaveri J, Barrow MP, Gunn GB, Lai S, Lewin JS, Rosenthal DI, Wang XS, Fuller CD, Hutcheson KA. Patient-Reported Outcome Measures of Long-Term Swallowing Function after Oropharyngeal Radiation Therapy: A Cross-Sectional Methods Comparison. International Journal of Radiation Oncology 102(3):e221-e222, 2018. e-Pub 2018.
Hutcheson KA, Ye R, Blanchard P, Gunn GB, Fuller CD, Lewin JS, Frank SJ. Two-Year Prospective Patient Reported Outcomes Related to Dysphagia After Intensity Modulated Proton Therapy for Oropharyngeal Cancer. International Journal of Radiation Oncology 100(5):1389, 2018. e-Pub 2018.
Elhalawani H, Volpe S, Barua S, Mohamed A, Yang P, Ng SP, Lai S, Hutcheson KA, Gunn GB, Court LE, Rao A, Fuller CD. Exploration of an Early Imaging Biomarker of Osteoradionecrosis in Oropharyngeal Cancer Patients: Case-Control Study of the Temporal Changes of Mandibular Radiomics Features. International Journal of Radiation Oncology 100(5):1363-1364, 2018. e-Pub 2018.
Ferrarotto R, Glisson BS, Bell D, Hutcheson KA, Phan J, Tran HT, Gibbs DL, Lee JJ, Gillison ML, Sikora AG, Gross ND. Checkpoint Inhibitors Assessment in Oropharynx Carcinoma (CIAO). J Clin Oncol 36(Suppl 5S, abstr TPS118), 2018. e-Pub 2018.
Dursteler A, Kamal M, Mohamed ASR, Eraj S, Meheissen MAM, Garden AS, Sturgis EM, Hutcheson KA, Lu C, Mendoza TR, Frank SJ, Morrison WH, Rosenthal DI, Fuller CD Gunn GB. Longitudinal assessment of chronic fatigue in oropharyngeal cancer patients after definitive radiation treatment. Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E533, 2017. e-Pub 2017.
Erajs S, Jomaa M, Rock CD, Mohamed ASR, Hutcheson KA, Sturgis EM, Lu C, Morrison WH, Rosenthal DI, Frank SJ, Garden AS, Fuller CD, Gunn GB. Long-term patient report outcomes following radiation therapy for early stage base of tongue carcinoma: a symptom assessment study. Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E336, 2017. e-Pub 2017.
Hutcheson KA, Nurgalieva Z, Gunn GB, Giordano S, Zhao H, Bhayani M, Lewis C. 2-Year prevalence of dysphagia and related outcomes in head and neck cancer survivors: an updated SEER-Medicare analysis. Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E342, 2017. e-Pub 2017.
Kamal M, Dursteler A, O'Donnell BP, Eraj S, Mohamed ASR, Cardenas C, Meheissen MAM, Garden AS, Mendoza TR, Sturgis EM, Hutcheson KA, Lu C, Aristophanous M, Frank SJ, Morrison WH, Rosenthal DI, Fuller CD, Gunn GB. Prospective validation and instrumental comparison of the MD Anderson Symptom Inventory—Head and Neck Module for assessment of radiation therapy–attributable late xerostomia. Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E538, 2017. e-Pub 2017.
Kamal M, Meheissen MAM, Mohamed ASR, Ding Y, Rostom Y, Hegazy N, Wang J, Elhalawani H, Phan J, Rosenthal DI, Lai SY, Hutcheson KA, Frank SJ, Garden AS, Gunn GB, Fuller CD. Prospective MRI assessment of longitudinal signal kinetics of salivary glands in head and neck cancer patients treated with radiation therapy. Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E345, 2017. e-Pub 2017.
Lewis C, Nurgalieva Z, Gunn GB, Zhao H, Giordano S, Bhayani M, Hutcheson KA. Trends in head and neck cancer post-treatment rehabilitation. Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E539, 2017. e-Pub 2017.
Meheissen MAM, Kamal M, Mohamed ASR, Ding Y, Rostom Y, Hegazy N, Elhalawani H, Barrow MP, Eraj S, Rock CD, Wang J, Phan J, Gunn GB, Garden AS, Rosenthal DI, Frank SJ, Hutcheson KA, Fuller CD. Prospective MRI assessment of serial dose-response kinetics of swallowing muscles in oropharyngeal cancer patients treated with radiation therapy and correlations with Dynamic Imaging Grade for Swallowing Toxicity (DIGEST). Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E357-E358, 2017. e-Pub 2017.
Rock CD, Jomaa M, Eraj S, Mohamed ASR, Meheissen MAM, Elhalawani H, Morrison WH, Phan J, Lai S, Sturgis EM, Hutcheson KA, Ferrarotto R, Frank SJ, Rosenthal DI, Fuller CD, Garden AS, Gunn GB. Long-term patient reported symptoms and quality of life in patients >65 following radiation therapy for early stage glottic carcinoma. Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E367-E368, 2017. e-Pub 2017.
Rock CD, Jomaa M, Eraj S, Mohamed ASR, Meheissen MAM, Elhalawani H, Morrison WH, Phan, J, Lai S, Sturgis EM, Hutcheson KA, Ferrarotto R, Frank SJ, Rosenthal DI, Fuller CD, Garden AS, Gunn GB. Long-term patient reported outcomes following treatment for locally advanced oropharyngeal carcinoma: results from a symptom assessment study. Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E368, 2017. e-Pub 2017.
Mulcahy CF, Mohamed A, Rosenthal DI, Hutcheson KA, Weber RS, Lai SY, Gunn GB, Garden AS, Zafereo M, Morrison WH, Lewin JS, Kies MS, El-Naggar AK, Fuller CD. Comorbidity and survival in locally advanced laryngeal cancer. J Clin Oncol 34(15 (May 20 supplement)):6038, 2016. e-Pub 2016.
Goepfert RP, Lewin JS, Barrow MP, Gunn GB, Fuller CD, Beadle BM, Garden AS, Rosenthal DI, Kies MS, Papadimitrakopoulou V, Lai S, Schwartz DL, Hutcheson KA. Prospective MD Anderson Dysphagia Inventory outcomes after nonsurgical treatment of locoregionally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 94(4):962-963, 2016. e-Pub 2016.
Warren BW, Mohamed ASR, Hutcheson KA, Gunn GB, Lewin JS, Lai S, Rosenthal DI, Garden AS, Fuller CD. Trismus dose-response assessment using quantitative volumetric measures in head and neck radiation therapy. Int J Radiat Oncol Biol Phys 94(4):965-966, 2016. e-Pub 2016.
Hutcheson KA, Sturgis EM, Xu L, Gunn GB, Fuller CD, Mohamed ASR, Lai S, Lewin JS, Chen D. Feeding tube use in patients with salivary gland malignancy. Int J Radiat Oncol Biol Phys 94(4):966, 2016. e-Pub 2016.
Hutcheson KA, Lin H, Yuk MM, Hubbard RM, Barrow MP, Gunn GB, Fuller CD, Garden AS, Lai S, Schwartz DL, Kies MS, Hanna EY, Goepfert RP, Lewin JS. Lower cranial neuropathy after oropharyngeal intensity modulated radiation therapy (IMRT): a prospective study and literature review. Int J Radiat Oncol Biol Phys 94(4):968, 2016. e-Pub 2016.
Tucker JR, Xu L, Sturgis EM, Hofstede TM, Chambers MS, Gunn GB, Fuller CD, Mohamed ASR, Lai S, Hutcheson KA. Osteoradionecrosis after radiation therapy for salivary gland malignancies. Int J Radiat Oncol Biol Phys 94(4):970, 2016. e-Pub 2016.
Messer JA, Mohamed ASR, Hutcheson KA, Ding Y, Wang J, Eichelberger H, French C, Rosenthal DI, Gunn GB, Fuller CD. Longitudinal characterization of MRI kinetics in irradiated dysphagia-related structures for nasopharyngeal carcinoma patients receiving IMRT. Int J Radiat Oncol Biol Phys 94(4):224, 2016. e-Pub 2016.
Goepfert RP, Lewin JS, Barrow MP, Gunn GB, Fuller CD, Beadle BM, Garden AS, Rosenthal DI, Kies MS, Papadimitrakopoulou V, Lai S, Gross N, Schwartz DL, Hutcheson KA. Long-term patient-reported dysphagia in low-risk oropharyngeal carcinoma after intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 94(4):340, 2016. e-Pub 2016.
Lee S, Spinks TE, Guzman AB, Weber RS, Hanna EY, Hessel AC, Beadle BM, Hutcheson KA, Incalcaterra J, Wood NM, Jones D, Feeley TW. Measuring value in bundled payments for head and neck cancer. J Clin Oncol 34(7_suppl):11, 2016. e-Pub 2016.
Hutcheson KA, Gunn GB, Gross N, Barrow MP, Kies MS, Garden AS, Schwartz DL, Lewin JS. Prospective longitudinal swallowing outcomes after chemotherapy and split-field IMRT for advanced-stage T1-2 oropharyngeal cancer. Int J Radiat Oncol Biol Phys 93(3):E316, 2015. e-Pub 2015.
Rosenthal DI, Mohamed ASR, Garden AS, Gunn GB, Zafereo M, Phan J, Lai S, Lewin JS, Hutcheson KA, Frank SJ, Beadle BM, Morrison WH, El-Naggar AK, Kocak E, Ginsberg L, Kies MS, Weber RS, Fuller CD. Long-term outcomes following multidisciplinary management of T3 larynx cancer. Int J Radiat Oncol Biol Phys 93(3):E340, 2015. e-Pub 2015.
Messer JA, Mohamed ASR, Ding Y, Wang J, Eichelberger H, French C, Rosenthal DI, Gunn GB, Hutcheson KA, Fuller CD. Characterization of MRI kinectics in irradiated swallowing-related structures for nasopharyngeal carcinoma patients received IMRT. Int J Radiat Oncol Biol Phys 93(3):E343, 2015. e-Pub 2015.
Dale TM, Hutcheson KA, Mohamed ASR, Gunn GB, Rosenthal DI, Fuller CD. Exploratory assessment of swallowing muscle dose volume parameters with chronic dysphagia in patients receiving head and neck chemoradiation therapy. Int J Radiat Oncol Biol Phys 93(3):S171-S172, 2015. e-Pub 2015.
Hutcheson KA, Barringer DA, Gunn B, Lai SY, Barrow M, Lewin JS. Late radiation-associated dysphagia (late-rad) after IMRT for oropharyngeal cancer. Dysphagia 30(5):597, 2015. e-Pub 2015.
Hutcheson KA. Late radiation-associated dysphagia (Late RAD) with lower cranial neuropathy after oropharyngeal IMRT. Oncology 29(4), 2015. e-Pub 2015.
Yuk M, Lewin JS, Gunn BG, Holsinger FC, Hutcheson KA. Late-radiation-associated dysphagia (late-rad) with lower cranial neuropathies (lcnp) in long-term oropharyngeal cancer (opc) survivors: case reports. Dysphagia 29(6):765, 2014. e-Pub 2014.
Holliday E, Garden AS, Fuller CD, Phan J, Gunn GB, Rosenthal DI, Beadle BM, Morrison WH, Zolcak-Uzel E, Zhang X, Zhu XR, Lewis G, Glisson BS, Hutcheson KA, Weber RS, El-Naggar AK, Hong J, Hung T, Frank SJ. Gastrostomy tube rates decrease by over 50% in patients with nasopharyngeal cancer treated with intensity modulated proton therapy (IMPT): a case-controlled study. Int J Radiat Oncol Biol Phys 90(1):S528, 2014. e-Pub 2014.
Lai S, Huang AT, Tang C, Hutcheson KA, Bender M, Beadle BM, Gold KA, Lewin JS. Identification and management of laryngeal carcinoma patients with risk factors for gastrostomy tube placement. Int J Radiat Oncol Biol Phys 90(1):S540-S541, 2014. e-Pub 2014.
Beadle BM, Liao K, Buchholz TA, Garden AS, Hutcheson KA, Guadagnolo B. Differential feeding tube placement and duration with IMRT for head and neck cancer: a SEER-Medicare analysis. Int J Radiat Oncol Biol Phys 90(1):S550-S551, 2014. e-Pub 2014.
Hutcheson KA, Bhayani M, Beadle B, Gold K, Shinn E, Lewin JS. Use it or lose it: swallowing during radiotherapy or chemoradiotherapy for pharyngeal cancers. Dysphagia 28(4):626, 2013. e-Pub 2013.
Shinn E, Garden A, Basen-Engquist K, Sheil C, Alvarez A, Hutcheson KA, Contreras N, Coyne J, Lewin JS. Initial results from Prepare: a randomized adherence intervention trial in head and neck cancer patients. Dysphagia 28(4):642, 2013. e-Pub 2013.
Frank SJ, Rosenthal DI, Ang K, Sturgis EM, Chambers MS, Gunn GB, Hutcheson KA, Zhu XR, Palmer MB, Garden AS. Gastrostomy tubes decrease by over 50% with intensity modulated proton therapy (IMPT) during the treatment of oropharyngeal cancer patients: a case–control study. Int J Radiat Oncol Biol Phys 87(2):S144, 2013. e-Pub 2013.
Gunn GB, Mendoza TR, Fuller CD, Wang XS, Frank SJ, Hutcheson KA, Hanna EY, Garden AS, Cleeland CS, Rosenthal DI. Drivers of patient-reported symptom interference during radiation or chemoradiation as detected by the MD Anderson Symptom Inventory – Head and Neck Module. Int J Radiat Oncol Biol Phys 87(2):S116, 2013. e-Pub 2013.
Hutcheson, K, Awan MJ, Mohamed ASR, Baron CA, Gunn GB, Rosenthal DI, Holsinger FC, Schwartz DL, Lewin JS, Fuller CD. Late radiation-associated dysphagia (RAD) and lower cranial neuropathy after oropharyngeal radiation therapy: a case–control dosimetric comparison. Int J Radiat Oncol Biol Phys 87(2):S143, 2013. e-Pub 2013.
Hutcheson KA, Lewin JS, Garden AS, Rosenthal DI, Weber RS, William WN, Gunn GB, Morrison WH, Fuller CD, Frank SJ. Early experience with IMPT for the treatment of oropharyngeal tumors: acute toxicities and swallowing-related outcomes. Int J Radiat Oncol Biol Phys 87(2):S604, 2013. e-Pub 2013.
Setton J, Lee NY, Huang S, Waldron J, O’Sullivan B, Zhang Z, Shi W, Rosenthal DI, Hutcheson KA, Garden AS. A multi-institution pooled analysis of g-tube dependence in patients with oropharyngeal cancer treated with definitive IMRT. Int J Radiat Oncol Biol Phys 88(2):S141, 2013. e-Pub 2013.
Buoy, S, Warneke C, Tang, X, Barbon, CEA, Macdonald, C, Hutcheson KA. Adoption of the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST™) by Speech-Language Pathologists (SLP) in Clinical Practice: A CFIR Guided Survey. DRS Spciety.
Barbon CE, Warneke CL, Buoy SN, Ariana J, Sahli, Tang X, Hutcheson KA. Exploring the Relationship Between IDDSI and DIGEST as Evidence of Clinical Utility of the Tools in Oncology Practice. Dysphagia Research Society Meeting (DRS).
Krekeler BN, Hopkins A, Vollman C, Kate, Davidson, Broderick E, Altaye M, Tabangin M, Martin-Harris B, Hutcheson K. Preliminary Validation of Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) for use in Post-Stroke Populations.
Sabry A, Rodriguez V, Hutcheson KA, Martino R. The Penetration Aspiration Scale (PAS): Comparing Airway Safety Ratings for the Initial Versus All Swallows of a Bolus. Dysphagia Research Society (DRS).
Korivi BR, Warneke CL, Shehata MA, Palmquist SM, Patnana M, Javadi S, Rao SP, Rauch RA, Elsayes KM, Valencia D, Hutcheson KA. Correlating Fluoroscopy Time of Modified Barium Swallow Exams with Dynamic Grade of Swallowing Toxicity Criteria: A 3-Year Single Institution Analysis. Dysphagia Research Society (DRS).
Dharmarathna I, Gandhi P, Panes V, Carly, Barbon, Steele CM, Hutcheson KA. A Comparison of Pixel-Based Measures of Bolus Clearance and DIGEST Efficiency Ratings. Dysphagia Research Society Meeting (DRS).
Ebersole B, Buoy S, Lango M, Schwartz T, Cunningham C, McMillan H, Porsche C, Barbon CEA, Goepfert R, Lai S, Hutcheson KA. Drivers of Reduced Social Communication After Laryngectomy in Tracheoesophageal Speakers. Survivorship Research Retreat.
Brooks KA, Gidley CG, Grimley O, Wang C, Jivani S, Roberts D, Naing A, Phan J, Hutcheson K, Wang X, Gidley P, Nader M. Incidence of Hearing Loss in Patients Treated with Immune Checkpoint Inhibitors. AAO-HNSF 2025 Call for Science : AAO-HNSF 2025 Annual Meeting & OTO EXPO.
Brooks KA, Gidley CG, Grimley O, Wang C, Jivani S, Roberts D, Naing A, Phan J, Hutcheson KA, Wang X, Gidley P, Nader M. Incidence of Hearing Loss in Patients Treated with Immune Checkpoint Inhibitors. AAO-HNSF 2025 Annual Meeting & OTO EXPO.
Burdick RJ, Wu J, Aldridge E, Rogus-Pulia N, Hutcheson K. DIGESTing with the inclusion of sequential swallowing tasks in a modified barium swallow study protocol. Dysphagia Research Society Meeting (DRS).
Borders JC, Grande AA, Barbon CE, Hutcheson KA, Troche MS. Effects of Statistical Practices for Longitudinal Group Comparison of the Penetration Aspiration Scale on Power and Effect Size Estimation: A Monte Carlo Simulation Study. Dysphagia Research Society Meeting (DRS).
Burdick RJ, Wu JJ, Terp CC, Gustafson SE, Yee JP, Rogus-Pulia N, Hutcheson K. Do Thickened Liquids in Modified Barium Swallow (MBS) Study Bolus Protocols Change Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) Grades?.
Manduchi B, Flamand Y, Ferris RL, Quon H, Weinstein GS, Mehra R, Garcia JJ, Peterson C, Barbon CEA, Lewis JS, Duvvuri U, Ozer E, Gross NB, Bell RB, Saba NF, Koch WMHutcheson KA, et al. BEYOND ASPIRATION: REVISITING RESIDUE RATES AND MBS SWALLOWPROFILES FROM THE ECOG-ACRIN E3311 TRIAL. AHNS Conference.
Manduchi B, Jefferson TC, Moreno AC, Barbon CEA, Fuller CD, Hutcheson KA. A SINGLE MDADI ITEM SUCCESSFULLY DETECTS IMAGING-GRADEDDYSPHAGIA (PER DIGEST) IN PATIENTS WITH HEAD AND NECK CANCERRECEIVING RADIOTHERAPY. AHNS Conference.
Buoy SN, Warneke C, Tang X“, Barbon CE, Macdonald C, Hutcheson K. Adoption of the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST™) by Speech-Language Pathologists (SLP) in Clinical Practice: A CFIR-Guided Survey. Dysphagia Research Society Meeting (DRS).
Manduchi B, Jefferson TC, Moreno AC, Barbon CEA, Fuller CD, Hutcheson KA. A SINGLE MDADI ITEM SUCCESSFULLY DETECTS IMAGING-GRADEDDYSPHAGIA (PER DIGEST) IN PATIENTS WITH HEAD AND NECK CANCERRECEIVING RADIOTHERAPY. AHNS Conference.
Manduchi B, Flamand Y, Ferris RL, Quon H, Weinstein GS, Mehra R, Garcia JJ, Peterson C, Barbon CEA, Lewis JS, Duvvuri U, Ozer E, Gross NB, Bell RB, Saba NF, Koch WMHutcheson KA, et al. BEYOND ASPIRATION: REVISITING RESIDUE RATES AND MBS SWALLOWPROFILES FROM THE ECOG-ACRIN E3311 TRIAL. AHNS Conference.
Manduchi B, Warneke CL, Buoy SN, Barbpm CEA, Hutcheson KA. Towards oncology-wide clinical implementation of DIGEST: validation across non-HNC oncology populations. Dysphagia Research Society Meeting (DRS).
Manduchi B, Jefferson TC, Moreno AC, Barbon CEA, Martino R, Fuller CD, Hutcheson KA. Utilizing prospective registry data to externally assess the pragmatic PROACTIVE patient-reported single item “trigger point. DRS Society.
Anderson BJ, Hutcheson KA. Feeding tube utilization in oropharynx cancer: A preliminary 6-year modern prospective registry analysis.
Hutcheson KA, Woodman K, Peterson C, Lynn R, Buoy S, McMillan H, Barbon C, Garcia J, Leak W, Lewis C, Su S, Hanna EY, Fuller CD, Lai SY. High dose steroid therapy for late lower cranial neuropathy: Preliminary results of an ongoing prospective registry.
McMillan H, Buoy S, Fuller CD, Lai SY, Warneke C, Hutcheson KA. EXPLORING DOMAINS OF SYMPTOM RELIEF WITH MANUAL THERAPY FOR LATE RADIATION-ASSOCIATED DYSPHAGIA: SECONDARY ANALYSIS OF THE PILOT MANTLE TRIAL. American Head and Neck Society Annual Meeting/Combine Otolaryngology.
Hutcheson, KA, Appana, SN, Tark, JY, Li, R, Sharma, SV, Satach, C, Roller, E, Sandulache, V, Oliveira D. Exploring dietary quality and insufficiencies in relation to swallow function and symptoms among HPV-positive oropharyngeal cancer patients. Dysphagia Research Society Meeting (DRS).
Nader ME, Choi J, Gidley PW, Hutcheson KA, Jivani S, Fernandez K, You C. The role of metformin in the prevention of cisplatin-induced ototoxicity. American Head and Neck Society.
Rao Korivi B, Shehata MA, Patnana M, Palmquist SM, Elsayes KM, Hutcheson KA. Utilizing DIGEST Criteria for Modified Barium Swallow Exams: The Proof is in the Pudding. Society for Advanced Body imaging.
Mao S, Naser M, Buoy S, Brock K, Hutcheson KA. Optimizing Modified Barium Swallow Exam Workflow: Automating Pre-Analysis Video Sorting in Swallowing Function Assessment. 46th Annual International Conference of the IEEE Engineering in Medicine & Biology Society.

Book Chapters

Hutcheson KA. Stell & Maran's Head and Neck Surgery and Oncology. In: Stell & Maran's Head and Neck Surgery and Oncology. Routledge Taylor & Francis Group, 2025.
Richardson, C, Hutcheson, KA. Swallowing and communication disorders in head and neck cancer, 157-181, 2024.
Anderson, JP, McMillan, H, Su, SY, Hutcheson, KA. Supportive Care for Patients with Sinonasal and Skull Base Tumors, 225-247, 2022.
Anderson, JP, McMillan, H, Su, SY, Hutcheson, KA. Correction to, C1, 2022.
Hutcheson KA, Lewin JS. Dysphagia in patients with head and neck cancer. In: Head and Neck Cancers: Evidenced-Based Treatment. Demos Medical Publishing, 457-477, 2018.
Lewin JS, Hutcheson KA. Speech and Swallowing Impairment. In: Body Image Care for Cancer Patients. 2018. Oxford University Press, 2018.
Roe JWG, Hutcheson KA. Swallowing, voice, and speech disorders after chemoradiation. In: Scott-Brown's Otorhinolaryngology, Head and Neck Surgery. 8th. CRC Press, 532, 2018.
Ferrell JK, Grossberg A Mohamed ASR, Fuller CD, Gold K, Hutcheson KA, Gross ND. Early HPV-related tonsil cancer. In: Oral, Head, and Neck Oncology and Reconstructive Surgery. 1st. Elsevier, 628-648, 2017.
Neskey DM, Hutcheson KA, Kupferman ME. Cancer of the oropharynx. In: Cancer of the Head and Neck. 5th. Wolters Kluwer, 347-368, 2017.
Hutcheson KA. Rehabilitation of heavily treated head and neck cancer patients. In: Head and Neck Cancer: Multimodality Management. 2nd. Springer, 783-798, 2016.
Hutcheson KA, Pytynia KB, Gunn GB. Cases in oropharyngeal cancer: a multidisciplinary approach. In: Overview of Multidisciplinary Management for Oropharyngeal Cancer. Plural Publishing Inc, 49-68, 2016.
Hutcheson KA. Speech therapy multidisciplinary commentary. Optimizing functional outcomes after oral cavity reconstruction: a rehabilitative perspective. In: Reconstructive Plastic Surgery of the Head and Neck: Current Techniques and Flap Atlas. Thieme Medical Publishers, Inc, 37-39, 2016.
Hutcheson KA, Lewin JS. Voice rehabilitation after laryngectomy. In: Sataloff's Comprehensive Textbook of Otolaryngology. Jaypee Medical Publishers, 759-770, 2016.
Hutcheson KA, Lewis CM. Head and neck cancer survivorship management. In: Advances in Cancer Survivorship Management (MD Anderson Cancer Care Series). Springer, 145-166, 2015.
Lewis CM, Hutcheson KA, Kupferman ME. Comparative effectiveness in head and neck malignancies. In: Comparative Effectiveness in Surgical Oncology. Springer, 89-99, 2015.
Lewin JS, Hutcheson KA. Evaluation and rehabilitation of speech, voice, and swallowing function after treatment of head and neck cancer. In: Head and Neck Cancer: A Multidisciplinary Approach. 4th. Lippincott, Williams & Wilkins, 225-235, 2013.
Lewin JS, Hutcheson KA, Barringer DA. Supracricoid laryngectomy (SCPL). In: Dysphagia in Rare Conditions. Plural Publishing Inc, 2009.
Lewin JS, Hutcheson KA. General principles of rehabilitation of speech, voice, and swallowing after treatment of head and neck cancer. In: Head and Neck Cancer: A Multidisciplinary Approach. 3rd. Lippincott Williams & Wilkins, 168-177, 2008.

Letters to the Editor

Macdonald C, Fitch M, Hutcheson KA, McCulloch TM, Martino R. A protocol for stakeholder engagement in head and neck cancer pragmatic trials. BMC Cancer 24: 1109, 2024.
McDowell, L, Hutcheson, KA, Ringash, J. Dysphagia-optimised intensity-modulated radiotherapy versus standard radiotherapy in patients with pharyngeal cancer. The lancet oncology 24: e396, 2023.

Less

Selected Presentations & Talks

Local Presentations

2025. Incidence of Hearing Loss in Patients Treated with Immune Checkpoint Inhibitors. AAO-HNSF 2025 Annual Meeting & OTO EXPO. Indianapolis, Indiana, US.
2025. Head and Neck Cancer related Dysphagia & Lymphedema. Invited. TIRR Memorial Hermann and MD Anderson Cancer Center present The 4th Cancer Rehabilitation Symposium (2025). Houston, Texas, US.
2025. DIGEST R01. Ohio State University. Columbus, OH, US.
2025. Manual Therapy for Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors: Results of the Prospective Pilot MANTLE trial. JAMA Otolaryngology-Head & Neck Surgery. Houston, Texas, US.

Formal Peers

2023. Radiation Associated Dysphagia "RAD" Pearls, Pitfalls, Progress. Invited. San Francisco, CA, US.
2023. The modified barium swallow: a primer. Invited. San Francisco, CA, US.
2023. Hypoglossal neuropathy as a latent effect of HN RT; The case for "pro-habilitation". Invited. San Francisco, CA, US.
2022. Dysphagia in Head and Neck Cancer. Invited, MD, US.
2021. Dysphagia Practice Research: Optimizing Swallowing Outcomes along the Continuum of Care. Invited. Cleveland, OH, US.
2021. Supportive care trials - Optimizing swallowing outcomes along the continuum of care. Invited, US.
2021. Supportive care trials - Optimizing swallowing outcomes along the continuum of care. Invited, US.
2021. Dysphagia in Head and Neck Cancer Optimizing outcomes through standard pathways and evaluation protocols. Invited, US.
2019. CPRIT Fellowship Alumni Panel. Invited. Houston, TX, US.
2017. Radiation-Associated Dysphagia. Invited. Detroit, MI, US.
2017. Videofluoroscopy in Head and Neck Cancer. Invited. London, GB.
2017. Department of Communication Sciences and Disorders 2017 Graduating Class Expert Panel. Invited. Houston, TX, US.
2015. Radiation-Associated Dysphagia. Invited. New York, NY, US.
2015. Radiation Associated Dysphagia: An Update. Invited. Chicago, IL, US.

Less

Grant & Contract Support

Date:	2026 - 2030
Title:	10-year follow-up of the PRO-ACTIVE RCT comparing the long-term effectiveness of PROphylACTic swallow InterVEntion in patients receiving radiotherapy for head and neck cancer (PRO-ACTIVE-10)
Funding Source:	Patient-Centered Outcomes Research Institute
Role:	PI
ID:	FP00023826

Date:	2025 - 2030
Title:	Harvard MD Anderson Collaborative to Reduce LyMphatic MOrbility in Head and Neck Cancer with Artificial Intelligence (HARMONiC-AI)
Funding Source:	NIH
Role:	Co-I
ID:	1R01DE034780

Date:	2025 - 2030
Title:	Decision Support for Stratified Oncologic Orodental Toxicity Surveillance
Funding Source:	NIH/NIDCR
Role:	Co-I
ID:	R01DE034964

Date:	2024 - 2029
Title:	OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVivorship
Funding Source:	NIH/NCI
Role:	PI
ID:	1P01CA285249-01A1

Date:	2024 - 2029
Title:	InHANCE: Imaging Innovation for Head And Neck Cancer Evaluation & Treatment Delivery
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	1P01CA278716-01A1

Date:	2024 - 2029
Title:	Understanding the Impact of Food and Nutrition Insecurity on Oropharyngeal Cancer Outcomes Across the Continuum of Cancer Care
Funding Source:	NIH (sub through University of Texas Health Science Center)
Role:	PI
ID:	FP00020475

Date:	2024 - 2027
Title:	Immune-Related Determinants of HPV-Associated Oropharyngeal Cancer Outcomes
Funding Source:	CPRIT
Role:	Collaborator
ID:	RP240125

Date:	2023 - 2028
Title:	OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVIvorship (Project 2- Optic Nerve)
Funding Source:	NIH/NCI
Role:	PI
ID:	1P01CA285249-01A1

Date:	2023 - 2028
Title:	OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVivorship (Project 3)
Funding Source:	NIH/NCI
Role:	Co-I
ID:	PAR-20-077

Date:	2023 - 2028
Title:	OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVIvorship (Admin Core)
Funding Source:	NIH/NCI
Role:	Core Leader
ID:	1P01CA285249-01A1

Date:	2023 - 2028
Title:	Mitigating head and neck lymphedema/fibrosis: Simultaneous Trial Of Pharmacotherapy with Integrated Imaging Biomarker Assessment for Reduction of RadiOtherapy SequlaE (STOP-PhI2BR2OSE)
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	1R01CA284364-01

Date:	2023 - 2028
Title:	Statistical Learning Modeling to Improve Head and Neck Dysphagia Prediction: STOP HN Dysphagia
Funding Source:	NIH/NIDCR
Role:	Collaborator
ID:	1R01DE033124-01

Date:	2023 - 2029
Title:	Individualized MRI-BCI neurofeedback applied to radiation-induced cranial neuropathy in oropharyngeal cancer patients: The iMAP RC trial
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	FP00017566

Date:	2023 - 2025
Title:	Hypoglossal neuropathy in the pathogenesis of radiation associated dysphagia (hRAD)
Funding Source:	NIH/NCI
Role:	PI
ID:	1R21CA273984-01 / FP00014732

Date:	2023 - 2028
Title:	Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast- Enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)
Funding Source:	NIH/NIDCR
Role:	Co-I
ID:	1U01DE032168-01A1

Date:	2023 - 2028
Title:	Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-Enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1U01DE032168-01A1 PAR-20-060 U01

Date:	2023 - 2025
Title:	A Phase II randomized study for integrating of PRO based pathway in patient care after radiotherapy or concurrent chemoradiation for head and neck cancer
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	FP00016489

Date:	2023 - 2028
Title:	Dissemination and implementation of DIGEST™ as an evidence-based measurement tool for dysphagia in cancer
Funding Source:	NIH/NCI
Role:	PI
ID:	1R01CA271223-01A1 FP00013681

Date:	2023 - 2028
Title:	Dissemination and implementation of DIGEST™ as an evidence-based measurement tool for dysphagia in cancer
Funding Source:	NIH/NCI
Role:	PI
ID:	1R01CA271223-01A1

Date:	2022 - 2025
Title:	Provider and Patient-generated Remote Oro-Dental Health Electronic Data Capture for Algorithmic Longitudinal Evaluation and Risk-Assessment (P2ROHE2AL2E2R)
Funding Source:	NIH/NIDCR
Role:	Co-Mentor
ID:	FP00011363

Date:	2022 - 2023
Title:	FLAP: Functional outcomes by oraL defect: needs Assessment and Patient-reported outcomes
Funding Source:	American Academy of Otolaryngology
Role:	Collaborator
ID:	FP00015662

Date:	2022 - 2027
Title:	OPC Survivor: Optimizing Oro-Pharyngeal Cancer Survivorship through Informatics-Based Cohort Validation and Maintenance for Research
Funding Source:	NIH/NCI
Role:	PI
ID:	FP00013519

Date:	2021 - 2026
Title:	inHANCE: Imaging Innovation for Head And Neck Cancer Evaluation & Treatment Delivery - MPI - PI Project 2
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	CA254866

Date:	2021 - 2025
Title:	Uncovering the Long-Term Impact of Oropharyngeal Cancer and Dysphagia on Dietary Quality and Nutrition among Veteran Cancer Survivors: U-DINE Study
Funding Source:	Department of Defense (DOD)
Role:	Co-PI
ID:	W81XWH-20-PRCRP-BHSA

Date:	2021 - 2025
Title:	Uncovering the Long-Term Impact of Oropharyngeal Cancer and Dysphagia on Dietary Quality and Nutrition Among Veteran Cancer Survivors: The U-DINE Study
Funding Source:	Department of Defense - United States Army Medical Research
Role:	Co-I
ID:	W81XWH-21-1-0243

Date:	2021 - 2026
Title:	Haptics and Machine Learning to Address Engagement and Adherence in Mobile Technology for Head-and-Neck Cancer Survivors
Funding Source:	University of California - San Diego
Role:	Co-I
ID:	FP00011184

Date:	2020 - 2022
Title:	Feasibility of Quantifying Objective Swallowing Imaging Data Endpoints in the Cooperative Group Setting: ECOG-3311 Pilot
Funding Source:	IRG
Role:	PI

Date:	2020 - 2021
Title:	COMBAT-COVID-19: Comprehensive Monitoring, Biomarkers, and Therapy Assessment study in cancer patients with known or suspected COVID-19
Funding Source:	NIH/NCI
Role:	Co-I
ID:	CA70907

Date:	2020 - Present
Title:	PRO-TECTOR: Pro Temporal Evaluation for Cancer Therapy of ORopharyngeal Patients
Funding Source:	Sub-Award through University of Illinois- Chicago
Role:	Co-I
ID:	FP00012253

Date:	2020 - 2021
Title:	Determining the clinical utility of the caregiver analysis of reported disorders (CARES) questionnaire
Funding Source:	McMaster University
Role:	M-DATT Co-Investigator
ID:	FP00010832

Date:	2020 - 2022
Title:	Stop LCNP: High Dose Steroid Therapy for Late Radiation-associated Lower Cranial Neuropathy
Funding Source:	HESI THRIVE
Role:	PI

Date:	2019 - 2020
Title:	Risk and protective factors for longterm hearing loss secondary to Cisplatin chemotherapy
Funding Source:	University of Texas MD Anderson Cancer Center Cancer Survivorship Research Seed Money Grants
Role:	Co-I

Date:	2019 - 2024
Title:	Center of Excellence in Rare Salivary Gland Cancers – Project 2: Patient-Centered Outcomes of Salivary Gland Tumors
Funding Source:	NIH/NCATS
Role:	Project Leader
ID:	FP00006323

Date:	2019 - 2024
Title:	Unobtrusive Wireless Sensing System for the Early Detection of Persistent Swallowing Dysfunction in Head and Neck Cancer Patients
Funding Source:	NIH/NIDCR
Role:	Co-I
ID:	1R01DE-01

Date:	2018 - 2020
Title:	Adaptation and Validation of the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) for Fiberoptic Endoscopic Evaluation of Swallowing (FEES)
Funding Source:	ASH Foundation (sub. through Stanford University)
Role:	Co-I
ID:	FP00005173

Date:	2018 - 2026
Title:	Elucidating Dynamics of Oral Polymicrobial Communities and Designing Synthetic Biofilms to Improve Oral Cancer Outcomes
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	RFA-DE-18-011

Date:	2018 - 2025
Title:	PRO-ACTIVE: Comparing the Effectiveness of PROphylACTic Swallow InterVEntion for Patients Receiving Radiotherapy for Head and Neck Cancer
Funding Source:	Patient-Centered Outcomes Research Institute
Role:	Co-PI
ID:	PCS-1609-36195

Date:	2018 - 2023
Title:	MD Anderson Cancer Center Head & Neck SPORE
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1P50CA217669-01A1

Date:	2018 - 2020
Title:	MOre-In: Modeling Oral Intake in Oropharyngeal Cancer Survivorship
Funding Source:	NIH/NIDCR
Role:	PI
ID:	FP00003642

Date:	2018 - 2022
Title:	Manual Therapy for Fibrosis-related Late Effect Dysphagia in Head and Neck Cancer Survivors: The MANTLE trial
Funding Source:	NIH/NCI
Role:	PI
ID:	5R21CA226200-02

Date:	2018 - 2023
Title:	Unobtrusive Wireless Sensing System for the Early Detection of Persistent Swallowing Dysfunction in Head and Neck Cancer Patients
Funding Source:	NIH/NIDCR
Role:	Co-I
ID:	1R01DE027651-01

Date:	2018 - 2023
Title:	Utility of Patient-Reported Outcomes in Care of Patients with Head & Neck Cancer
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA225649-01

Date:	2018 - 2021
Title:	Use It or Lose It: A Randomized Phase II Trial of High and Low Intensity Preventive Swallowing Therapy During Head and Neck Cancer Radiotherapy
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	PI
ID:	FP00002630

Date:	2017 - 2019
Title:	Functional Translation of Manual Therapy to Fibrosis-Related Late Dysphagia in Oropharyngeal Cancer Survivors
Funding Source:	MD Anderson Oropharynx Program, Discover Section
Role:	PI

Date:	2017 - 2022
Title:	iRAD: Imaging Radiation-Associated Dysphagia
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	5R01CA218148-02

Date:	2017 - 2020
Title:	Improving Our Understanding of Dysphagia-Related Late Health Effects in Head and Neck Cancer Survivors: A Population-Based Analysis
Funding Source:	NIDCD
Role:	Co-I
ID:	NIDCD

Date:	2017 - 2018
Title:	Bayesian Phase II Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-I
ID:	RP170426

Date:	2016 - 2018
Title:	A Phase I Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Advanced Laryngeal Cancer
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-I
ID:	RP150386

Date:	2016 - 2018
Title:	PRO-CIAO Patient-Reported Outcomes of Checkpoint Inhibitors in Oropharynx Carcinoma
Funding Source:	NRG Oncology Foundation, Inc
Role:	PI
ID:	FF2017-00053419-HM

Date:	2016 - 2017
Title:	Characterization of Laryngectomy Stoma Structure-Function
Funding Source:	Gromada
Role:	Co-I
ID:	Pending

Date:	2016 - 2021
Title:	Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis
Funding Source:	NIH/NIDCR
Role:	Co-I
ID:	1R01DE025248-03

Date:	2015 - 2017
Title:	Toward Preventing Pneumonia in Chronic Aspirators after Head and Neck Radiotherapy
Funding Source:	The University of Texas MD Anderson Cancer Center Institutional Survivorship Seed Money Research Grant
Role:	PI
ID:	2015-00051041

Date:	2015 - 2016
Title:	Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Osteoradionecrosis
Funding Source:	NIH/NIDCR
Role:	Co-I
ID:	1R56DE025248-01

Date:	2015 - 2017
Title:	Optimizing Post-Treatment Surveillance of Head and Neck Cancer
Funding Source:	The University of Texas MD Anderson Cancer Center Institutional Survivorship Seed Money Research Grant
Role:	Co-I
ID:	2016-0051896

Date:	2015 - 2018
Title:	Lingual Strength & Dysphagia after Oropharynx Cancer: Proton vs. Photon Radiation
Funding Source:	NIH/NCI
Role:	PI
ID:	1R03CA188162-01A1

Date:	2015 - 2020
Title:	Patient-Centered Outcomes for Clinical Studies of Salivary Gland Tumors
Funding Source:	NIH/NCI
Role:	PI
ID:	R01DE025240-01

Date:	2015 - 2020
Title:	Translational Studies to Reduce Fatigue, Pain and Other Symptoms in Patients Treated for Head and Neck Cancer
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-I

Date:	2015 - 2016
Title:	Effect of Early Palliative/Supportive Care Consultation on Opioid Usage in Head and Neck Cancer Survivors After Curative Radiation Therapy
Funding Source:	MDACC
Role:	Co-I

Date:	2014 - 2023
Title:	Patient-Reported Outcomes/Function (PROF) Section
Funding Source:	Steifel Oropharyngeal Research Fund
Role:	PI
ID:	2016-00051834

Date:	2014 - 2019
Title:	Mechanisms of Symptoms of Cancer Therapy in HPV-Positive Head and Neck Cancer
Funding Source:	NIH/NCI
Role:	Co-I
ID:	P01CA124787-06

Date:	2014 - 2019
Title:	Pathogenic Stratification of Patients with Salivary Gland Malignancies (Project 2. Genetic Risk Factors for Salivary Gland Carcinoma and Outcomes of Therapy)
Funding Source:	NIH/NCI
Role:	Co-Project Leader with Dr. Erich M. Sturgis

Date:	2014 - 2019
Title:	The Role of Protons vs. Photons to Reduce Toxicity in Head and Neck Cancer Therapy
Funding Source:	NIH/NCI
Role:	Co-I
ID:	Award # Pending

Date:	2014 - 2018
Title:	Videofluoroscopic Grading of Dysphagia in Organ Preservation Trials
Funding Source:	MD Anderson Cancer Center - Institutional Research Grant
Role:	PI
ID:	2016-00052317

Date:	2014 - 2018
Title:	Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)
Funding Source:	Velindre NHS Trust (Prime: Cancer Research United Kingdom)
Role:	Co-I
ID:	C36244/A17161

Date:	2013 - 2017
Title:	Determining the Extent of Dysphagia using the Modified Barium Swallow for RTOG 1221, a Randomized Phase II Trial of Transoral Endoscopic Head and Neck Surgery followed by Risk-Based IMRT and Weekly Cisplatin versus IMRT and Weekly Cisplatin for HPV Negative Oropharynx Cancer
Funding Source:	Radiation Therapy Oncology Group (BIQSFP)
Role:	Co-I
ID:	RTOG 1221

Date:	2012 - 2015
Title:	Media-Rich Mobile Health Dissemination Strategies for Targeted Swallowing Exercise Programs in Irradiated Head and Neck Cancer
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Collaborator

Date:	2012 - 2015
Title:	Late Effects and Intervention Needs of Head & Neck Cancer Survivors
Funding Source:	American Cancer Society (ACS)
Role:	PI
ID:	MDACC#12021960

Date:	2012 - Present
Title:	NIR Fluorescence Imaging for Assessment of Lymphatics in Cancer Treatment and Recovery
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Consult
ID:	RP120941

Date:	2011 - 2013
Title:	A Measurement Protocol for Head & Neck Lymphedema
Funding Source:	NIH/NIDCR
Role:	Co-I
ID:	1R21DE022447-01

Date:	2011 - 2013
Title:	A Retrospective Review of the MD Anderson Experience with the Provox NiD Prosthesis
Funding Source:	ATOS Medical, Inc
Role:	Co-I
ID:	CS2012-00035931LG 01

Date:	2011 - 2013
Title:	UT Health Innovation for Cancer Prevention Research Fellowship, The University of Texas School of Public Health
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Research Fellow

Date:	2006 - 2019
Title:	Neurobehavioral Toxicities of Treatment for Head and Neck Cancer
Funding Source:	NIH/NCI
Role:	Co-I

Title:	Validation of Dynamic Imaging Grade Swallowing Toxicity (DIGEST) in Parkinson's disease
Funding Source:	American Parkinson's Disease Association
Role:	Consult

Title:	Proactive exercise-based tongue intervention on swallow function and tongue muscle pathology in a translational model of chemoradiation therapy
Funding Source:	NIH/NCI
Role:	Co-Sponser
ID:	13692883

Title:	Orodental Post-therapeutic Oncologic and Toxicity Modeling to Understand Multi-Outcome Phenotypes for Locoregional Head and Neck Cancer Survivors (OPTOMUM-PLANS)
Funding Source:	University of Illinois- Chicago
Role:	Co-I
ID:	FP00016708

Title:	Computational Analytics in Treatment-Induced Adverse Longitudinal Sequelae for Toxicity Ameliorating Interventions (CATALYST-AI)
Funding Source:	University of Illinois- Chicago
Role:	Co-I
ID:	FP00016707

CV information above last modified May 29, 2025

Katherine A. Hutcheson, Ph.D.

About Dr. Katherine A. Hutcheson

Present Title & Affiliation

Primary Appointment

Research Interests

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Other Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Professional Memberships

Selected Publications

Peer-Reviewed Articles

Invited Articles

Manuals, Teaching Aids, Other Teaching Publications

Other Articles

Editorials

Abstracts

Book Chapters

Letters to the Editor

Selected Presentations & Talks

Local Presentations

Formal Peers

Grant & Contract Support

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

Katherine A. Hutcheson, Ph.D.

About Dr. Katherine A. Hutcheson

Present Title & Affiliation

Primary Appointment

Research Interests

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Other Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Professional Memberships

Selected Publications

Peer-Reviewed Articles

Invited Articles

Manuals, Teaching Aids, Other Teaching Publications

Other Articles

Editorials

Abstracts

Book Chapters

Letters to the Editor

Selected Presentations & Talks

Local Presentations

Formal Peers

Grant & Contract Support

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Volunteer